| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | ABCB1 SLC22A13 SLC23A2 SLC26A9 SLC6A15 GRIK5 SLC3A1 SLC6A6 SLC6A8 SLC6A13 SLC7A1 SLC6A5 SLC16A8 | 2.63e-07 | 207 | 207 | 13 | GO:0046943 |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | ABCB1 SLC22A13 SLC23A2 SLC26A9 SLC6A15 GRIK5 SLC3A1 SLC6A6 SLC6A8 SLC6A13 SLC7A1 SLC6A5 SLC16A8 | 2.78e-07 | 208 | 207 | 13 | GO:0005342 |
| GeneOntologyMolecularFunction | organic acid:sodium symporter activity | 1.46e-06 | 35 | 207 | 6 | GO:0005343 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | ANO9 ABCA3 UQCR10 NDUFV1 CHRNB3 ABCB1 SV2B SLC22A13 KCNJ4 SLC9B2 SCN8A TRPV2 SLC23A2 CACNA1B SLC31A1 SLC26A9 SLC6A15 OCA2 GRIK5 SLC35F1 PKD1L3 SLC3A1 SLC6A6 SLC6A8 SLC6A13 SLC7A1 SLC6A5 SLC15A5 SLC45A2 SLC4A4 SLC16A8 | 1.69e-06 | 1180 | 207 | 31 | GO:0022857 |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | ABCB1 SLC22A13 SLC23A2 SLC26A9 SLC6A15 GRIK5 SLC3A1 SLC6A6 SLC6A8 SLC6A13 SLC7A1 SLC6A5 SLC4A4 SLC16A8 | 2.43e-06 | 293 | 207 | 14 | GO:0008514 |
| GeneOntologyMolecularFunction | amino acid:sodium symporter activity | 3.30e-06 | 23 | 207 | 5 | GO:0005283 | |
| GeneOntologyMolecularFunction | transporter activity | ANO9 ABCA3 CETP UQCR10 NDUFV1 CHRNB3 ABCB1 SV2B SLC22A13 KCNJ4 SLC9B2 SCN8A TRPV2 SLC23A2 CACNA1B SLC31A1 SLC26A9 SLC6A15 OCA2 GRIK5 SLC35F1 PKD1L3 SLC3A1 SLC6A6 SLC6A8 SLC6A13 SLC7A1 SLC6A5 SLC15A5 SLC45A2 SLC4A4 SLC16A8 | 3.72e-06 | 1289 | 207 | 32 | GO:0005215 |
| GeneOntologyMolecularFunction | symporter activity | SLC23A2 SLC6A15 SLC6A6 SLC6A8 SLC6A13 SLC6A5 SLC15A5 SLC45A2 SLC4A4 SLC16A8 | 3.83e-06 | 150 | 207 | 10 | GO:0015293 |
| GeneOntologyMolecularFunction | amino acid:monoatomic cation symporter activity | 1.11e-05 | 29 | 207 | 5 | GO:0005416 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | SLC9B2 SCN8A SLC23A2 SLC6A15 GRIK5 SLC6A6 SLC6A8 SLC6A13 SLC6A5 SLC4A4 | 1.22e-05 | 171 | 207 | 10 | GO:0015081 |
| GeneOntologyMolecularFunction | amino acid transmembrane transporter activity | 1.37e-05 | 105 | 207 | 8 | GO:0015171 | |
| GeneOntologyMolecularFunction | solute:sodium symporter activity | 2.11e-05 | 81 | 207 | 7 | GO:0015370 | |
| GeneOntologyMolecularFunction | gamma-aminobutyric acid:sodium:chloride symporter activity | 2.15e-05 | 6 | 207 | 3 | GO:0005332 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | ANO9 UQCR10 NDUFV1 CHRNB3 KCNJ4 SLC9B2 SCN8A TRPV2 SLC23A2 CACNA1B SLC31A1 SLC26A9 SLC6A15 OCA2 GRIK5 PKD1L3 SLC6A6 SLC6A8 SLC6A13 SLC6A5 SLC45A2 SLC4A4 | 2.74e-05 | 793 | 207 | 22 | GO:0015075 |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | 3.41e-05 | 119 | 207 | 8 | GO:0015294 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | ABCA3 UQCR10 NDUFV1 ABCB1 SLC9B2 SLC23A2 SLC26A9 SLC6A15 SLC6A6 SLC6A8 SLC6A13 SLC6A5 SLC15A5 SLC45A2 SLC4A4 SLC16A8 | 4.01e-05 | 477 | 207 | 16 | GO:0022804 |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | ANO9 UQCR10 NDUFV1 KCNJ4 SLC9B2 SCN8A TRPV2 SLC23A2 CACNA1B SLC31A1 SLC26A9 SLC6A15 OCA2 GRIK5 PKD1L3 SLC6A6 SLC6A8 SLC6A13 SLC6A5 SLC45A2 SLC4A4 | 4.29e-05 | 758 | 207 | 21 | GO:0015318 |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | SLC9B2 SLC23A2 SLC26A9 SLC6A15 SLC6A6 SLC6A8 SLC6A13 SLC6A5 SLC15A5 SLC45A2 SLC4A4 SLC16A8 | 6.45e-05 | 296 | 207 | 12 | GO:0015291 |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | UQCR10 NDUFV1 CHRNB3 KCNJ4 SLC9B2 SCN8A TRPV2 SLC23A2 CACNA1B SLC31A1 SLC6A15 GRIK5 PKD1L3 SLC6A6 SLC6A8 SLC6A13 SLC6A5 SLC45A2 SLC4A4 | 6.59e-05 | 664 | 207 | 19 | GO:0008324 |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | UQCR10 NDUFV1 SLC9B2 SLC23A2 SLC26A9 SLC6A15 SLC6A6 SLC6A8 SLC6A13 SLC6A5 SLC45A2 SLC4A4 | 7.57e-05 | 301 | 207 | 12 | GO:0022853 |
| GeneOntologyMolecularFunction | gamma-aminobutyric acid transmembrane transporter activity | 8.81e-05 | 9 | 207 | 3 | GO:0015185 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | UQCR10 NDUFV1 KCNJ4 SLC9B2 SCN8A TRPV2 SLC23A2 CACNA1B SLC31A1 SLC6A15 GRIK5 PKD1L3 SLC6A6 SLC6A8 SLC6A13 SLC6A5 SLC45A2 SLC4A4 | 9.89e-05 | 627 | 207 | 18 | GO:0022890 |
| GeneOntologyMolecularFunction | carbamoyl-phosphate synthase (ammonia) activity | 1.07e-04 | 2 | 207 | 2 | GO:0004087 | |
| GeneOntologyMolecularFunction | carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity | 1.07e-04 | 2 | 207 | 2 | GO:0004088 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | KCNJ4 SLC9B2 SCN8A TRPV2 SLC23A2 CACNA1B SLC31A1 SLC6A15 GRIK5 PKD1L3 SLC6A6 SLC6A8 SLC6A13 SLC6A5 SLC4A4 | 1.08e-04 | 465 | 207 | 15 | GO:0046873 |
| GeneOntologyMolecularFunction | carbon-nitrogen ligase activity, with glutamine as amido-N-donor | 1.25e-04 | 10 | 207 | 3 | GO:0016884 | |
| GeneOntologyMolecularFunction | PDZ domain binding | 2.99e-04 | 123 | 207 | 7 | GO:0030165 | |
| GeneOntologyMolecularFunction | taurine:sodium symporter activity | 3.19e-04 | 3 | 207 | 2 | GO:0005369 | |
| GeneOntologyMolecularFunction | iron-responsive element binding | 3.19e-04 | 3 | 207 | 2 | GO:0030350 | |
| GeneOntologyMolecularFunction | aconitate hydratase activity | 3.19e-04 | 3 | 207 | 2 | GO:0003994 | |
| GeneOntologyMolecularFunction | polyamine oxidase activity | 3.19e-04 | 3 | 207 | 2 | GO:0046592 | |
| GeneOntologyMolecularFunction | monocarboxylate:sodium symporter activity | 4.56e-04 | 15 | 207 | 3 | GO:0140161 | |
| GeneOntologyMolecularFunction | NADP binding | 4.57e-04 | 62 | 207 | 5 | GO:0050661 | |
| GeneOntologyMolecularFunction | olfactory receptor activity | OR5T3 OR9A4 OR1B1 OR4D9 OR7D2 OR4F17 OR4D11 OR52R1 OR52A4P OR10AC1 OR2Y1 OR4B1 OR4A4P | 5.88e-04 | 431 | 207 | 13 | GO:0004984 |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor | 6.33e-04 | 4 | 207 | 2 | GO:0016647 | |
| GeneOntologyMolecularFunction | creatine transmembrane transporter activity | 6.33e-04 | 4 | 207 | 2 | GO:0005308 | |
| GeneOntologyMolecularFunction | sodium:chloride symporter activity | 6.71e-04 | 17 | 207 | 3 | GO:0015378 | |
| GeneOntologyMolecularFunction | secondary active monocarboxylate transmembrane transporter activity | 9.41e-04 | 19 | 207 | 3 | GO:0015355 | |
| GeneOntologyMolecularFunction | monoatomic anion:sodium symporter activity | 9.41e-04 | 19 | 207 | 3 | GO:0015373 | |
| GeneOntologyMolecularFunction | NAD binding | 9.67e-04 | 73 | 207 | 5 | GO:0051287 | |
| GeneOntologyMolecularFunction | monoatomic anion transmembrane transporter activity | 1.02e-03 | 151 | 207 | 7 | GO:0008509 | |
| GeneOntologyMolecularFunction | fatty acid omega-1 hydroxylase activity | 1.05e-03 | 5 | 207 | 2 | GO:0120502 | |
| GeneOntologyMolecularFunction | long-chain fatty acid omega-1 hydroxylase activity | 1.05e-03 | 5 | 207 | 2 | GO:0120319 | |
| GeneOntologyMolecularFunction | taurine transmembrane transporter activity | 1.05e-03 | 5 | 207 | 2 | GO:0005368 | |
| GeneOntologyMolecularFunction | iron-sulfur cluster binding | 1.30e-03 | 78 | 207 | 5 | GO:0051536 | |
| GeneOntologyMolecularFunction | 4 iron, 4 sulfur cluster binding | 1.41e-03 | 47 | 207 | 4 | GO:0051539 | |
| GeneOntologyMolecularFunction | chloride:monoatomic cation symporter activity | 1.67e-03 | 23 | 207 | 3 | GO:0015377 | |
| GeneOntologyMolecularFunction | metal cluster binding | 1.72e-03 | 83 | 207 | 5 | GO:0051540 | |
| GeneOntologyMolecularFunction | chloride transmembrane transporter activity | 1.95e-03 | 125 | 207 | 6 | GO:0015108 | |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | 2.08e-03 | 171 | 207 | 7 | GO:0015103 | |
| GeneOntologyMolecularFunction | ribosomal protein S6 kinase activity | 2.17e-03 | 7 | 207 | 2 | GO:0004711 | |
| GeneOntologyMolecularFunction | alkali metal ion binding | 2.39e-03 | 26 | 207 | 3 | GO:0031420 | |
| GeneOntologyMolecularFunction | monoatomic anion:monoatomic cation symporter activity | 2.39e-03 | 26 | 207 | 3 | GO:0015296 | |
| GeneOntologyMolecularFunction | monocarboxylic acid transmembrane transporter activity | 2.46e-03 | 90 | 207 | 5 | GO:0008028 | |
| GeneOntologyMolecularFunction | oxidoreductase activity | CYP2C9 CYP2E1 UQCR10 PGD FMO6P NDUFV1 PTGR3 ME3 PAOX FOXRED2 CRYZL1 IL4I1 NOS1 AOX1 HIBADH PDHX AASS | 2.68e-03 | 766 | 207 | 17 | GO:0016491 |
| GeneOntologyMolecularFunction | neutral L-amino acid:sodium symporter activity | 2.87e-03 | 8 | 207 | 2 | GO:0005295 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-NH group of donors | 3.63e-03 | 30 | 207 | 3 | GO:0016645 | |
| GeneOntologyMolecularFunction | cell-matrix adhesion mediator activity | 3.67e-03 | 9 | 207 | 2 | GO:0098634 | |
| GeneOntologyMolecularFunction | sulfur compound transmembrane transporter activity | 3.69e-03 | 61 | 207 | 4 | GO:1901682 | |
| GeneOntologyBiologicalProcess | carboxylic acid metabolic process | CYP2C9 HK3 CYP2E1 AMACR ACO1 IREB2 PGD PTGR3 ME3 SLC22A13 IL4I1 NOS1 SLC23A2 ACSL6 CAD ASRGL1 OCA2 PPARG CPS1 HIBADH GBA2 PDHX SLC6A8 SIRT2 AASS ASNS SLC45A2 SLC4A4 ENO1 MMUT ACSL5 | 3.45e-08 | 1035 | 204 | 31 | GO:0019752 |
| GeneOntologyBiologicalProcess | oxoacid metabolic process | CYP2C9 HK3 CYP2E1 AMACR ACO1 IREB2 PGD PTGR3 ME3 SLC22A13 IL4I1 NOS1 SLC23A2 ACSL6 CAD ASRGL1 OCA2 PPARG CPS1 HIBADH GBA2 PDHX SLC6A8 SIRT2 AASS ASNS SLC45A2 SLC4A4 ENO1 MMUT ACSL5 | 5.67e-08 | 1058 | 204 | 31 | GO:0043436 |
| GeneOntologyBiologicalProcess | organic acid metabolic process | CYP2C9 HK3 CYP2E1 AMACR ACO1 IREB2 PGD PTGR3 ME3 SLC22A13 IL4I1 NOS1 SLC23A2 ACSL6 CAD ASRGL1 OCA2 PPARG CPS1 HIBADH GBA2 PDHX SLC6A8 SIRT2 AASS ASNS SLC45A2 SLC4A4 ENO1 MMUT ACSL5 | 6.44e-08 | 1064 | 204 | 31 | GO:0006082 |
| GeneOntologyBiologicalProcess | organic acid transmembrane transport | ABCB1 SLC23A2 ACSL6 SLC6A15 SLC3A1 SLC6A6 SLC6A8 SLC6A13 SLC7A1 SLC6A5 SLC16A8 ACSL5 | 1.09e-07 | 167 | 204 | 12 | GO:1903825 |
| GeneOntologyBiologicalProcess | carboxylic acid transmembrane transport | ABCB1 SLC23A2 ACSL6 SLC6A15 SLC3A1 SLC6A8 SLC6A13 SLC7A1 SLC6A5 SLC16A8 ACSL5 | 6.99e-07 | 163 | 204 | 11 | GO:1905039 |
| GeneOntologyBiologicalProcess | carboxylic acid transport | RPS6KB1 ABCB1 SLC22A13 SLC23A2 ACSL6 SLC26A9 SLC6A15 PPARG SLC3A1 SLC6A6 SLC6A8 SLC6A13 SLC7A1 SLC6A5 SLC16A8 ACSL5 | 3.47e-06 | 410 | 204 | 16 | GO:0046942 |
| GeneOntologyBiologicalProcess | organic acid transport | RPS6KB1 ABCB1 SLC22A13 SLC23A2 ACSL6 SLC26A9 SLC6A15 PPARG SLC3A1 SLC6A6 SLC6A8 SLC6A13 SLC7A1 SLC6A5 SLC16A8 ACSL5 | 3.69e-06 | 412 | 204 | 16 | GO:0015849 |
| GeneOntologyBiologicalProcess | sodium ion transmembrane transport | WNK1 SLC9B2 SCN8A NOS1 SLC23A2 SLC6A15 SLC6A6 SLC6A8 SLC6A13 SLC6A5 SLC4A4 | 7.49e-06 | 208 | 204 | 11 | GO:0035725 |
| GeneOntologyBiologicalProcess | organic anion transport | RPS6KB1 ABCB1 SLC22A13 SLC23A2 ACSL6 SLC26A9 SLC6A15 PPARG SLC3A1 SLC6A6 SLC6A8 SLC6A13 SLC7A1 SLC6A5 SLC4A4 SLC16A8 ACSL5 | 1.55e-05 | 515 | 204 | 17 | GO:0015711 |
| GeneOntologyBiologicalProcess | import across plasma membrane | WNK1 KCNJ4 TRPV2 CACNA1B ACSL6 SLC31A1 SLC6A6 SLC6A13 SLC7A1 SLC6A5 ACSL5 | 1.92e-05 | 230 | 204 | 11 | GO:0098739 |
| GeneOntologyBiologicalProcess | sodium ion transport | WNK1 SLC9B2 SCN8A DMPK NOS1 SLC23A2 SLC6A15 SLC6A6 SLC6A8 SLC6A13 SLC6A5 SLC4A4 | 2.00e-05 | 275 | 204 | 12 | GO:0006814 |
| GeneOntologyBiologicalProcess | alpha-amino acid metabolic process | IL4I1 NOS1 CAD ASRGL1 OCA2 CPS1 HIBADH AASS ASNS SLC45A2 MMUT | 4.29e-05 | 251 | 204 | 11 | GO:1901605 |
| GeneOntologyBiologicalProcess | proteinogenic amino acid metabolic process | 9.74e-05 | 185 | 204 | 9 | GO:0170039 | |
| GeneOntologyBiologicalProcess | monocarboxylic acid metabolic process | CYP2C9 HK3 CYP2E1 AMACR PGD PTGR3 ME3 SLC22A13 IL4I1 ACSL6 PPARG GBA2 PDHX SLC6A8 SIRT2 SLC4A4 ENO1 MMUT ACSL5 | 1.25e-04 | 731 | 204 | 19 | GO:0032787 |
| GeneOntologyBiologicalProcess | positive regulation of small molecule metabolic process | 1.29e-04 | 192 | 204 | 9 | GO:0062013 | |
| GeneOntologyBiologicalProcess | cellular response to iron ion | 1.48e-04 | 11 | 204 | 3 | GO:0071281 | |
| GeneOntologyBiologicalProcess | import into cell | MYO7B RPS6KB1 DNER ITGA2 WNK1 SYNJ2 KCNJ4 SLC9B2 TRPV2 NOS1 CACNA1B ACSL6 SLC31A1 POT1 PPARG TFR2 SLC6A6 SLC6A13 SLC7A1 SIRT2 CD9 ITSN2 SLC6A5 ACSL5 | 1.65e-04 | 1074 | 204 | 24 | GO:0098657 |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception | OR5T3 OR9A4 OR1B1 OR4D9 ITGA2 ADGRV1 OR7D2 OR4F17 OR4D11 PKD1L3 OR52R1 OR52A4P OR10AC1 OR2Y1 OR4B1 OR4A4P | 2.33e-04 | 582 | 204 | 16 | GO:0050906 |
| GeneOntologyBiologicalProcess | L-amino acid metabolic process | 2.35e-04 | 208 | 204 | 9 | GO:0170033 | |
| GeneOntologyBiologicalProcess | response to iron ion | 2.37e-04 | 31 | 204 | 4 | GO:0010039 | |
| GeneOntologyBiologicalProcess | neurotransmitter transport | SV2B NOS1 CACNA1B PPFIA2 SLC6A15 GRIK5 SLC6A6 SLC6A8 SLC6A13 SLC6A5 | 2.68e-04 | 259 | 204 | 10 | GO:0006836 |
| GeneOntologyBiologicalProcess | protein localization to chromosome, telomeric region | 2.69e-04 | 32 | 204 | 4 | GO:0070198 | |
| GeneOntologyBiologicalProcess | multicellular organismal-level iron ion homeostasis | 2.69e-04 | 32 | 204 | 4 | GO:0060586 | |
| GeneOntologyBiologicalProcess | positive regulation of long-chain fatty acid import across plasma membrane | 2.90e-04 | 3 | 204 | 2 | GO:0010747 | |
| GeneOntologyBiologicalProcess | chemorepulsion involved in embryonic olfactory bulb interneuron precursor migration | 2.90e-04 | 3 | 204 | 2 | GO:0021834 | |
| GeneOntologyBiologicalProcess | small molecule catabolic process | HK3 AMACR OXCT2 PGD SYNJ2 IL4I1 NOS1 ASRGL1 HIBADH AASS ENO1 URAD ACSL5 | 3.03e-04 | 421 | 204 | 13 | GO:0044282 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception | OR5T3 OR9A4 OR1B1 OR4D9 OR7D2 OR4F17 OR4D11 PKD1L3 OR52R1 OR52A4P OR10AC1 OR2Y1 OR4B1 OR4A4P | 3.53e-04 | 485 | 204 | 14 | GO:0050907 |
| GeneOntologyBiologicalProcess | circulatory system process | ITGA9 WNK1 ABCB1 SCN8A TMEM65 DMPK NOS1 SLC23A2 CACNA1B PPARG CPS1 ARHGAP35 SLC6A6 TGFBR3 SLC6A13 SLC7A1 SLC4A4 EPAS1 | 3.75e-04 | 733 | 204 | 18 | GO:0003013 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception of smell | OR5T3 OR9A4 OR1B1 OR4D9 OR7D2 OR4F17 OR4D11 OR52R1 OR52A4P OR10AC1 OR2Y1 OR4B1 OR4A4P | 3.87e-04 | 432 | 204 | 13 | GO:0050911 |
| GeneOntologyBiologicalProcess | sensory perception | OR5T3 OR9A4 OR1B1 MYO7B OR4D9 ITGA2 ADGRV1 OR7D2 SCN8A TRPV2 OR4F17 RBP3 OR4D11 PKD1L3 PKHD1L1 OR52R1 OR52A4P OR10AC1 OR2Y1 SLC45A2 OR4B1 EPAS1 OR4A4P | 4.05e-04 | 1072 | 204 | 23 | GO:0007600 |
| GeneOntologyBiologicalProcess | organophosphate metabolic process | SMG1 ABCA3 HK3 CETP OXCT2 PGD NDUFV1 SYNJ2 SLC22A13 PYGL NOS1 VCP GPLD1 ACSL6 CAD CPS1 PDHX PDXK AASS SLC4A4 ENO1 URAD MMUT ACSL5 | 4.07e-04 | 1142 | 204 | 24 | GO:0019637 |
| GeneOntologyBiologicalProcess | positive regulation of telomere maintenance via telomerase | 4.27e-04 | 36 | 204 | 4 | GO:0032212 | |
| Domain | NA_NEUROTRAN_SYMP_2 | 1.08e-06 | 18 | 202 | 5 | PS00754 | |
| Domain | SNF | 1.45e-06 | 19 | 202 | 5 | PF00209 | |
| Domain | Na/ntran_symport | 1.45e-06 | 19 | 202 | 5 | IPR000175 | |
| Domain | NA_NEUROTRAN_SYMP_1 | 1.45e-06 | 19 | 202 | 5 | PS00610 | |
| Domain | NA_NEUROTRAN_SYMP_3 | 1.45e-06 | 19 | 202 | 5 | PS50267 | |
| Domain | LAM_G_DOMAIN | 3.07e-06 | 38 | 202 | 6 | PS50025 | |
| Domain | Laminin_G_2 | 4.20e-06 | 40 | 202 | 6 | PF02210 | |
| Domain | LamG | 7.45e-06 | 44 | 202 | 6 | SM00282 | |
| Domain | Laminin_G | 3.77e-05 | 58 | 202 | 6 | IPR001791 | |
| Domain | - | 7.71e-05 | 95 | 202 | 7 | 2.60.120.200 | |
| Domain | EGF-like_dom | CNTNAP3B DNER CNTNAP3 VWDE FAT2 GP2 FRAS1 LAMA2 SLIT1 SLIT3 MUC3A | 8.79e-05 | 249 | 202 | 11 | IPR000742 |
| Domain | CarbamoylP_synth_ssu | 1.16e-04 | 2 | 202 | 2 | IPR006274 | |
| Domain | CarbamoylP_synth_lsu | 1.16e-04 | 2 | 202 | 2 | IPR006275 | |
| Domain | Aconitase/IRP2 | 1.16e-04 | 2 | 202 | 2 | IPR006249 | |
| Domain | CPSase_sm_chain | 1.16e-04 | 2 | 202 | 2 | SM01097 | |
| Domain | CPSase_L_D3 | 1.16e-04 | 2 | 202 | 2 | SM01096 | |
| Domain | CbamoylP_synth_lsu_CPSase_dom | 1.16e-04 | 2 | 202 | 2 | IPR005483 | |
| Domain | CarbamoylP_synth_lsu_oligo | 1.16e-04 | 2 | 202 | 2 | IPR005480 | |
| Domain | CPSase_sm_chain | 1.16e-04 | 2 | 202 | 2 | PF00988 | |
| Domain | Pgluconate_DH | 1.16e-04 | 2 | 202 | 2 | IPR006183 | |
| Domain | CPSase_L_D3 | 1.16e-04 | 2 | 202 | 2 | PF02787 | |
| Domain | - | 1.16e-04 | 2 | 202 | 2 | 3.50.30.20 | |
| Domain | - | 1.16e-04 | 2 | 202 | 2 | 1.10.1030.10 | |
| Domain | CarbamoylP_synth_ssu_N | 1.16e-04 | 2 | 202 | 2 | IPR002474 | |
| Domain | EGF | CNTNAP3B DNER CNTNAP3 VWDE FAT2 FRAS1 LAMA2 SLIT1 SLIT3 MUC3A | 2.49e-04 | 235 | 202 | 10 | SM00181 |
| Domain | AconitaseA/IPMdHydase_ssu_swvl | 3.47e-04 | 3 | 202 | 2 | IPR000573 | |
| Domain | Aconitase_C | 3.47e-04 | 3 | 202 | 2 | PF00694 | |
| Domain | TRAM1 | 3.47e-04 | 3 | 202 | 2 | PF08390 | |
| Domain | - | 3.47e-04 | 3 | 202 | 2 | 3.30.499.10 | |
| Domain | MGS-like_dom | 3.47e-04 | 3 | 202 | 2 | IPR011607 | |
| Domain | 6PGDH_NADP-bd | 3.47e-04 | 3 | 202 | 2 | IPR006115 | |
| Domain | MGS | 3.47e-04 | 3 | 202 | 2 | PF02142 | |
| Domain | NAD_binding_2 | 3.47e-04 | 3 | 202 | 2 | PF03446 | |
| Domain | Acoase/IPM_deHydtase_lsu_aba | 3.47e-04 | 3 | 202 | 2 | IPR001030 | |
| Domain | - | 3.47e-04 | 3 | 202 | 2 | 3.40.1060.10 | |
| Domain | - | 3.47e-04 | 3 | 202 | 2 | 3.20.19.10 | |
| Domain | Acoase/IPM_deHydtase | 3.47e-04 | 3 | 202 | 2 | IPR015937 | |
| Domain | Acnase/IPM_dHydase_lsu_aba_1/3 | 3.47e-04 | 3 | 202 | 2 | IPR015931 | |
| Domain | Aconitase/IPMdHydase_lsu_aba_2 | 3.47e-04 | 3 | 202 | 2 | IPR015932 | |
| Domain | ACONITASE_1 | 3.47e-04 | 3 | 202 | 2 | PS00450 | |
| Domain | Aconitase/3IPM_dehydase_swvl | 3.47e-04 | 3 | 202 | 2 | IPR015928 | |
| Domain | Aconitase | 3.47e-04 | 3 | 202 | 2 | PF00330 | |
| Domain | MGS | 3.47e-04 | 3 | 202 | 2 | SM00851 | |
| Domain | Aconitase_4Fe-4S_BS | 3.47e-04 | 3 | 202 | 2 | IPR018136 | |
| Domain | - | 3.47e-04 | 3 | 202 | 2 | 3.40.50.1380 | |
| Domain | Translocation_assoc_membrane | 3.47e-04 | 3 | 202 | 2 | IPR016447 | |
| Domain | ACONITASE_2 | 3.47e-04 | 3 | 202 | 2 | PS01244 | |
| Domain | TRAM1 | 3.47e-04 | 3 | 202 | 2 | IPR013599 | |
| Domain | EGF_1 | 4.75e-04 | 255 | 202 | 10 | PS00022 | |
| Domain | EGF_2 | 6.40e-04 | 265 | 202 | 10 | PS01186 | |
| Domain | ConA-like_dom | 6.50e-04 | 219 | 202 | 9 | IPR013320 | |
| Domain | COE | 6.88e-04 | 4 | 202 | 2 | PS01345 | |
| Domain | Transcription_factor_COE | 6.88e-04 | 4 | 202 | 2 | IPR003523 | |
| Domain | COE_HLH | 6.88e-04 | 4 | 202 | 2 | IPR032201 | |
| Domain | COE_DBD | 6.88e-04 | 4 | 202 | 2 | IPR032200 | |
| Domain | Transcription_factor_COE_CS | 6.88e-04 | 4 | 202 | 2 | IPR018350 | |
| Domain | COE1_HLH | 6.88e-04 | 4 | 202 | 2 | PF16423 | |
| Domain | COE1_DBD | 6.88e-04 | 4 | 202 | 2 | PF16422 | |
| Domain | Int_alpha | 1.06e-03 | 19 | 202 | 3 | SM00191 | |
| Domain | Int_alpha_beta-p | 1.06e-03 | 19 | 202 | 3 | IPR013519 | |
| Domain | EGF_3 | 1.07e-03 | 235 | 202 | 9 | PS50026 | |
| Domain | GATase | 1.14e-03 | 5 | 202 | 2 | PF00117 | |
| Domain | CPSASE_1 | 1.14e-03 | 5 | 202 | 2 | PS00866 | |
| Domain | DUF4704 | 1.14e-03 | 5 | 202 | 2 | IPR031570 | |
| Domain | DUF4704 | 1.14e-03 | 5 | 202 | 2 | PF15787 | |
| Domain | FG_GAP | 1.65e-03 | 22 | 202 | 3 | PS51470 | |
| Domain | PH_BEACH | 1.70e-03 | 6 | 202 | 2 | PF14844 | |
| Domain | GATASE_TYPE_1 | 1.70e-03 | 6 | 202 | 2 | PS51273 | |
| Domain | GATASE | 1.70e-03 | 6 | 202 | 2 | IPR017926 | |
| Domain | CPSASE_2 | 1.70e-03 | 6 | 202 | 2 | PS00867 | |
| Domain | FG-GAP | 2.13e-03 | 24 | 202 | 3 | PF01839 | |
| Domain | FG-GAP | 2.13e-03 | 24 | 202 | 3 | IPR013517 | |
| Domain | EGF-like_CS | 2.20e-03 | 261 | 202 | 9 | IPR013032 | |
| Domain | CbamoylP_synth_lsu-like_ATP-bd | 2.36e-03 | 7 | 202 | 2 | IPR005479 | |
| Domain | BC-like_N | 2.36e-03 | 7 | 202 | 2 | IPR005481 | |
| Domain | Quin_OxRdtase/zeta-crystal_CS | 2.36e-03 | 7 | 202 | 2 | IPR002364 | |
| Domain | QOR_ZETA_CRYSTAL | 2.36e-03 | 7 | 202 | 2 | PS01162 | |
| Domain | CPSase_L_D2 | 2.36e-03 | 7 | 202 | 2 | PF02786 | |
| Domain | Biotin_carb_N | 2.36e-03 | 7 | 202 | 2 | PF00289 | |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | CETP ACO1 ADGRV1 PGD ABCB1 SLC22A13 GNAI1 VASP VCP TCP1 PPFIA2 AOX1 HUWE1 PKD1L3 PDXK SLC3A1 BROX TGFBR3 SLC6A13 CD9 TLN1 ITSN2 SLC4A4 | 4.94e-08 | 1016 | 207 | 23 | 19056867 |
| Pubmed | The repertoire of solute carriers of family 6: identification of new human and rodent genes. | 1.34e-07 | 21 | 207 | 5 | 16125675 | |
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | MAN2B1 MCM6 WNK1 SEC23B VPS26B USP24 CCT7 HUWE1 CPS1 PDXK TLN1 ASNS ENO1 | 1.73e-07 | 344 | 207 | 13 | 30333137 |
| Pubmed | 2.08e-07 | 3 | 207 | 3 | 24842606 | ||
| Pubmed | The IRP1-HIF-2α axis coordinates iron and oxygen sensing with erythropoiesis and iron absorption. | 2.08e-07 | 3 | 207 | 3 | 23395174 | |
| Pubmed | IRP1 regulates erythropoiesis and systemic iron homeostasis by controlling HIF2α mRNA translation. | 2.08e-07 | 3 | 207 | 3 | 23777768 | |
| Pubmed | 8.28e-07 | 4 | 207 | 3 | 34593646 | ||
| Pubmed | Network organization of the huntingtin proteomic interactome in mammalian brain. | CPNE2 RPS6KA1 UQCR10 NDUFV1 PYGL NOS1 VCP ACSL6 ANK1 TCP1 CCT7 GRIK5 HUWE1 SIRT2 CD9 ENO1 | 1.14e-06 | 621 | 207 | 16 | 22794259 |
| Pubmed | FAM120B ITGA2 NDUFV1 SBF1 SV2B GNAI1 PLCL1 NOS1 VCP ACSL6 CAD ASRGL1 CARMIL2 TCP1 PPFIA2 RBP3 CCT7 NBEA ARHGAP35 PDHX PDXK SIRT2 TLN1 ITSN2 SLC4A4 | 1.58e-06 | 1431 | 207 | 25 | 37142655 | |
| Pubmed | 2.10e-06 | 16 | 207 | 4 | 17715346 | ||
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | MAN2B1 ACO1 RPS6KA1 IREB2 MCM6 WNK1 PGD BNIP2 CIAPIN1 BUB1B PYGL COG5 VASP SEC23B VCP CUL4A TCP1 POLR1C USP24 CCT7 HUWE1 TRNT1 TLN1 ASNS PARVA | 2.13e-06 | 1455 | 207 | 25 | 22863883 |
| Pubmed | 3.12e-06 | 104 | 207 | 7 | 36055981 | ||
| Pubmed | MAN2B1 UGT3A1 ME3 PYGL CUL4A AOX1 PPARG PDHX NLRP3 SLC3A1 MMUT | 3.15e-06 | 313 | 207 | 11 | 20800603 | |
| Pubmed | 3.49e-06 | 18 | 207 | 4 | 31791063 | ||
| Pubmed | SMG1 ACO1 BTBD1 WNK1 MAP3K5 ARID1B BNIP2 MYO18B VCP LAMA2 TLN1 TNKS ENO1 | 1.01e-05 | 497 | 207 | 13 | 23414517 | |
| Pubmed | 1.10e-05 | 49 | 207 | 5 | 18936436 | ||
| Pubmed | Genetic variants in nuclear-encoded mitochondrial genes influence AIDS progression. | HK3 AMACR ACO1 IREB2 UQCR10 NDUFV1 PTGR3 ME3 TMEM65 MTRF1L CCT7 CPS1 HIBADH PDHX TRNT1 AASS MMUT ACSL5 | 1.23e-05 | 926 | 207 | 18 | 20877624 |
| Pubmed | MET Inhibitors Promote Liver Tumor Evasion of the Immune Response by Stabilizing PDL1. | 1.45e-05 | 182 | 207 | 8 | 30711629 | |
| Pubmed | PPARγ Interaction with UBR5/ATMIN Promotes DNA Repair to Maintain Endothelial Homeostasis. | 1.70e-05 | 90 | 207 | 6 | 30699358 | |
| Pubmed | 1.70e-05 | 9 | 207 | 3 | 9693030 | ||
| Pubmed | A mitochondrial protein compendium elucidates complex I disease biology. | HK3 AMACR ACO1 OXCT2 IREB2 UQCR10 NDUFV1 PTGR3 ME3 ABCB1 TMEM65 MTRF1L CCT7 HIBADH PDHX TRNT1 AASS MMUT ACSL5 | 1.82e-05 | 1047 | 207 | 19 | 18614015 |
| Pubmed | 2.56e-05 | 197 | 207 | 8 | 36604605 | ||
| Pubmed | Interaction of hydroxylated collagen IV with the von hippel-lindau tumor suppressor. | 3.31e-05 | 11 | 207 | 3 | 17339318 | |
| Pubmed | Amino acid transport across mammalian intestinal and renal epithelia. | 3.38e-05 | 31 | 207 | 4 | 18195088 | |
| Pubmed | A regulated RNA binding protein also possesses aconitase activity. | 3.53e-05 | 2 | 207 | 2 | 1946430 | |
| Pubmed | 3.53e-05 | 2 | 207 | 2 | 14726953 | ||
| Pubmed | Effect of hypoxia on the binding and subcellular distribution of iron regulatory proteins. | 3.53e-05 | 2 | 207 | 2 | 17200797 | |
| Pubmed | ASK1 inhibition reduces cell death and hepatic fibrosis in an Nlrp3 mutant liver injury model. | 3.53e-05 | 2 | 207 | 2 | 31996485 | |
| Pubmed | 3.53e-05 | 2 | 207 | 2 | 23401652 | ||
| Pubmed | In vivo role(s) of the iron regulatory proteins (IRP) 1 and 2 in aseptic local inflammation. | 3.53e-05 | 2 | 207 | 2 | 19533074 | |
| Pubmed | 3.53e-05 | 2 | 207 | 2 | 15831703 | ||
| Pubmed | Iron misregulation and neurodegenerative disease in mouse models that lack iron regulatory proteins. | 3.53e-05 | 2 | 207 | 2 | 25771171 | |
| Pubmed | 3.53e-05 | 2 | 207 | 2 | 8262972 | ||
| Pubmed | 3.53e-05 | 2 | 207 | 2 | 15588114 | ||
| Pubmed | Sirt2-BubR1 acetylation pathway mediates the effects of advanced maternal age on oocyte quality. | 3.53e-05 | 2 | 207 | 2 | 29067790 | |
| Pubmed | 3.53e-05 | 2 | 207 | 2 | 16503547 | ||
| Pubmed | Self-association and ligand-induced conformational changes of iron regulatory proteins 1 and 2. | 3.53e-05 | 2 | 207 | 2 | 15938636 | |
| Pubmed | 3.53e-05 | 2 | 207 | 2 | 26807827 | ||
| Pubmed | 3.53e-05 | 2 | 207 | 2 | 8524831 | ||
| Pubmed | 3.53e-05 | 2 | 207 | 2 | 2172968 | ||
| Pubmed | Red meat intake, CYP2E1 and PPARγ polymorphisms, and colorectal cancer risk. | 3.53e-05 | 2 | 207 | 2 | 30489355 | |
| Pubmed | 3.53e-05 | 2 | 207 | 2 | 18816302 | ||
| Pubmed | 3.53e-05 | 2 | 207 | 2 | 8982604 | ||
| Pubmed | 3.53e-05 | 2 | 207 | 2 | 31857693 | ||
| Pubmed | Dysregulation of CLOCK gene expression in hyperoxia-induced lung injury. | 3.53e-05 | 2 | 207 | 2 | 24696144 | |
| Pubmed | 3.53e-05 | 2 | 207 | 2 | 31150793 | ||
| Pubmed | 3.53e-05 | 2 | 207 | 2 | 20556576 | ||
| Pubmed | 3.53e-05 | 2 | 207 | 2 | 22941809 | ||
| Pubmed | 3.53e-05 | 2 | 207 | 2 | 17604281 | ||
| Pubmed | 3.53e-05 | 2 | 207 | 2 | 24368600 | ||
| Pubmed | Oxidative Stress Orchestrates MAPK and Nitric-Oxide Synthase Signal. | 3.53e-05 | 2 | 207 | 2 | 33228180 | |
| Pubmed | Activation of the NLRP3 Inflammasome Is Associated with Valosin-Containing Protein Myopathy. | 3.53e-05 | 2 | 207 | 2 | 27730320 | |
| Pubmed | [A new, rapid and robust genotyping method for CYP2C9 and MDR1]. | 3.53e-05 | 2 | 207 | 2 | 12805007 | |
| Pubmed | 3.53e-05 | 2 | 207 | 2 | 18389626 | ||
| Pubmed | Mammalian tissue oxygen levels modulate iron-regulatory protein activities in vivo. | 3.53e-05 | 2 | 207 | 2 | 15604406 | |
| Pubmed | Subcellular localization of iron regulatory proteins to Golgi and ER membranes. | 3.53e-05 | 2 | 207 | 2 | 16144863 | |
| Pubmed | Electron tomography of degenerating neurons in mice with abnormal regulation of iron metabolism. | 3.53e-05 | 2 | 207 | 2 | 15866737 | |
| Pubmed | 3.53e-05 | 2 | 207 | 2 | 24096233 | ||
| Pubmed | Targeted disruption of p70(s6k) defines its role in protein synthesis and rapamycin sensitivity. | 3.53e-05 | 2 | 207 | 2 | 9560223 | |
| Pubmed | 3.53e-05 | 2 | 207 | 2 | 26238426 | ||
| Pubmed | The association of aberrant expression of NLRP3 and p-S6K1 in colorectal cancer. | 3.53e-05 | 2 | 207 | 2 | 31757663 | |
| Pubmed | Iron regulatory proteins secure mitochondrial iron sufficiency and function. | 3.53e-05 | 2 | 207 | 2 | 20674864 | |
| Pubmed | 3.53e-05 | 2 | 207 | 2 | 27749554 | ||
| Pubmed | 3.53e-05 | 2 | 207 | 2 | 30114619 | ||
| Pubmed | SLC45A2 protein stability and regulation of melanosome pH determine melanocyte pigmentation. | 3.53e-05 | 2 | 207 | 2 | 32966160 | |
| Pubmed | 3.53e-05 | 2 | 207 | 2 | 8041788 | ||
| Pubmed | Generation of conditional alleles of the murine Iron Regulatory Protein (IRP)-1 and -2 genes. | 3.53e-05 | 2 | 207 | 2 | 16283625 | |
| Pubmed | 3.53e-05 | 2 | 207 | 2 | 38301068 | ||
| Pubmed | 3.53e-05 | 2 | 207 | 2 | 23395173 | ||
| Pubmed | 3.53e-05 | 2 | 207 | 2 | 17495181 | ||
| Pubmed | 3.53e-05 | 2 | 207 | 2 | 15208438 | ||
| Pubmed | Circadian clock-controlled intestinal expression of the multidrug-resistance gene mdr1a in mice. | 3.53e-05 | 2 | 207 | 2 | 18773899 | |
| Pubmed | 3.53e-05 | 2 | 207 | 2 | 21566147 | ||
| Pubmed | 3.53e-05 | 2 | 207 | 2 | 25285631 | ||
| Pubmed | 3.53e-05 | 2 | 207 | 2 | 16002074 | ||
| Pubmed | 3.53e-05 | 2 | 207 | 2 | 20354189 | ||
| Pubmed | 3.53e-05 | 2 | 207 | 2 | 22331484 | ||
| Pubmed | 3.53e-05 | 2 | 207 | 2 | 7983023 | ||
| Pubmed | 3.53e-05 | 2 | 207 | 2 | 24394537 | ||
| Pubmed | 3.53e-05 | 2 | 207 | 2 | 35820936 | ||
| Pubmed | Iron regulatory proteins increase neuronal vulnerability to hydrogen peroxide. | 3.53e-05 | 2 | 207 | 2 | 18655771 | |
| Pubmed | Effects of iron regulatory protein regulation on iron homeostasis during hypoxia. | 3.53e-05 | 2 | 207 | 2 | 12855587 | |
| Pubmed | 3.53e-05 | 2 | 207 | 2 | 28970254 | ||
| Pubmed | 3.53e-05 | 2 | 207 | 2 | 34505419 | ||
| Pubmed | 3.53e-05 | 2 | 207 | 2 | 38773499 | ||
| Pubmed | 3.53e-05 | 2 | 207 | 2 | 32050049 | ||
| Pubmed | Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation. | 3.77e-05 | 208 | 207 | 8 | 33230847 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | SCN8A ANK1 TCP1 PPFIA2 PCDHB12 SLC26A9 NBEA GRIK5 HUWE1 SLC6A6 RANBP3L TLN1 ASNS OR4B1 ZNF304 | 3.91e-05 | 736 | 207 | 15 | 29676528 |
| Pubmed | 4.08e-05 | 105 | 207 | 6 | 30280653 | ||
| Pubmed | Blocking an N-terminal acetylation-dependent protein interaction inhibits an E3 ligase. | MCM6 ADGRV1 BTBD1 PGD PYGL VCP CUL4A CAD TCP1 CCT7 HUWE1 ENO1 | 4.63e-05 | 495 | 207 | 12 | 28581483 |
| Pubmed | 4.78e-05 | 108 | 207 | 6 | 19956635 | ||
| Pubmed | Genetic susceptibility to distinct bladder cancer subphenotypes. | CYP2C9 CYP2E1 CETP AMACR ABCB1 SLC23A2 POT1 OCA2 PPARG TNKS SEC14L2 | 4.94e-05 | 421 | 207 | 11 | 19692168 |
| Pubmed | Identification of Zika Virus and Dengue Virus Dependency Factors using Functional Genomics. | NDUFV1 S100A11 PYGL GNAI1 VCP TCP1 CCT7 HUWE1 CPS1 TLN1 ENO1 | 5.04e-05 | 422 | 207 | 11 | 27342126 |
| Pubmed | A Large-scale genetic association study of esophageal adenocarcinoma risk. | CYP2C9 CYP2E1 ITGA2 ABCB1 BUB1B ZNF624 ASCC3 SLC23A2 HUS1B PPARG | 5.32e-05 | 351 | 207 | 10 | 20453000 |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | MCM6 BTBD1 NDUFV1 FOXRED2 ASCC3 COG5 VCP POLR1C USP24 SLC6A15 APLP2 HUWE1 URGCP SLC7A1 TLN1 ASNS PUM1 | 5.44e-05 | 942 | 207 | 17 | 31073040 |
| Pubmed | Exome sequencing reveals pathogenic mutations in 91 strains of mice with Mendelian disorders. | 7.20e-05 | 72 | 207 | 5 | 25917818 | |
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | CPNE2 MAN2B1 CETP ACO1 PGD ABCB1 S100A11 PYGL VCP GP2 GPLD1 TCP1 BROX CD9 TLN1 ENO1 SEC14L2 CPNE7 | 8.02e-05 | 1070 | 207 | 18 | 23533145 |
| Pubmed | 8.15e-05 | 172 | 207 | 7 | 27375898 | ||
| Pubmed | 8.21e-05 | 74 | 207 | 5 | 26332085 | ||
| Pubmed | 8.53e-05 | 300 | 207 | 9 | 19086053 | ||
| GeneFamily | Solute carriers | SLC22A13 SLC9B2 SLC23A2 SLC31A1 SLC26A9 SLC6A15 SLC35F1 SLC3A1 SLC6A6 SLC6A8 SLC6A13 SLC7A1 SLC6A5 SLC15A5 SLC45A2 SLC4A4 SLC16A8 | 3.58e-09 | 395 | 130 | 17 | 752 |
| Coexpression | CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_UP | 9.18e-06 | 175 | 202 | 9 | M16496 | |
| Coexpression | BROWNE_HCMV_INFECTION_20HR_DN | 1.45e-05 | 102 | 202 | 7 | M5601 | |
| Coexpression | GSE29618_PRE_VS_DAY7_FLU_VACCINE_BCELL_DN | 2.27e-05 | 196 | 202 | 9 | M4973 | |
| Coexpression | GSE10240_IL17_VS_IL17_AND_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_DN | 2.55e-05 | 199 | 202 | 9 | M312 | |
| Coexpression | GSE21670_STAT3_KO_VS_WT_CD4_TCELL_DN | 2.55e-05 | 199 | 202 | 9 | M7454 | |
| Coexpression | RODRIGUES_NTN1_TARGETS_DN | 3.71e-05 | 161 | 202 | 8 | M11857 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | LSM5 SYNJ2 BUB1B ARHGAP29 GNAI1 ASCC3 COG5 SLC23A2 ENC1 USP24 ARHGAP35 CLOCK TGFBR3 SLC7A1 BAZ1A ITSN2 TNKS TRAM2 PUM1 | 3.82e-05 | 856 | 202 | 19 | M4500 |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ADAMTS19 MYO7B ADGRV1 CHRNB3 CACNA1B FRAS1 PPFIA2 LAMA2 CPS1 PKHD1L1 AASS | 2.55e-10 | 160 | 207 | 11 | c381ec6be8cf887861cc18f831a20db42f953fe1 |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ADAMTS19 MYO7B ADGRV1 CHRNB3 CACNA1B FRAS1 PPFIA2 LAMA2 CPS1 PKHD1L1 AASS | 2.55e-10 | 160 | 207 | 11 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | MYO7B ADGRV1 DNAH5 FRAS1 ANK1 PPFIA2 SLC35F1 CPS1 PKHD1L1 SLC4A4 | 1.63e-08 | 184 | 207 | 10 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | MYO7B ADGRV1 DNAH5 FRAS1 ANK1 PPFIA2 SLC35F1 CPS1 PKHD1L1 SLC4A4 | 1.63e-08 | 184 | 207 | 10 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | MYO7B ADGRV1 DNAH5 FRAS1 ANK1 PPFIA2 SLC35F1 CPS1 PKHD1L1 SLC4A4 | 1.63e-08 | 184 | 207 | 10 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.10e-08 | 189 | 207 | 10 | f51cdc9a47371cab8ed9ae63a6f14da07ede446c | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | CNTNAP3 ADGRV1 S100A11 PYGL NOS1 VASP AOX1 CPS1 PKD1L3 MUC3A | 2.83e-08 | 195 | 207 | 10 | 19853c654ac64b3ae3bc99841c6cb29c8aaba85c |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | CNTNAP3 ADGRV1 S100A11 PYGL NOS1 VASP AOX1 CPS1 PKD1L3 MUC3A | 2.83e-08 | 195 | 207 | 10 | d3755929ebbbf5e3afde44281e9056ddb614a291 |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.52e-07 | 177 | 207 | 9 | bde307e67ad8e48a5ff4c0827015f4688f6b3e46 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | CNTNAP3B CNTNAP3 ABCB1 SYNJ2 SLC6A15 SLIT1 SLIT3 SNTG2 SLC4A4 | 1.76e-07 | 180 | 207 | 9 | b514c55e52b46e8a1a2f09ed2c59a7683367a505 |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | ADAMTS19 CNTNAP3B CNTNAP3 ABCB1 SYNJ2 SV2B SLIT1 SLIT3 SNTG2 | 1.84e-07 | 181 | 207 | 9 | 08f44323bf71b6004a921bbc969c954c75feeb66 |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-kidney_proximal_convoluted_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.93e-07 | 182 | 207 | 9 | faf0dfa3adc2d2706b6942b5127093ccdc856447 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Epcam____kidney_proximal_convoluted_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.93e-07 | 182 | 207 | 9 | be8dd52898525ce6632af0adc2801944f3ac10bd | |
| ToppCell | droplet-Marrow-nan-21m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.02e-07 | 183 | 207 | 9 | 71ea92cd20683230af314ff883b2624bd68382e1 | |
| ToppCell | COVID-19-lung-Vein_EC|lung / Disease (COVID-19 only), tissue and cell type | CNTNAP3B ABCB1 ARHGAP29 NOS1 ASRGL1 PKHD1L1 TGFBR3 SNTG2 EPAS1 | 2.54e-07 | 188 | 207 | 9 | d582b76fc2faac526c9bf97503041129e1a6a211 |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | CNTNAP3B CNTNAP3 ITGA9 SV2B ARHGAP29 PKHD1L1 SLC7A1 CD9 SNTG2 | 2.66e-07 | 189 | 207 | 9 | 55a1776a4ce049959b3f13a43744c7314bc1f00a |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.78e-07 | 190 | 207 | 9 | b94df372bc08de11585b2467dba8c8fffff5cd92 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.93e-07 | 198 | 207 | 9 | 688b0eb5534dde40b8630ab8a3252c816711e02e | |
| ToppCell | LPS_only-Hematopoietic_Myeloid|LPS_only / Treatment groups by lineage, cell group, cell type | 4.10e-07 | 199 | 207 | 9 | 20523dee39a4c5f6423259920f108127b47525c4 | |
| ToppCell | COVID-19-kidney-Lymphatic_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.76e-07 | 148 | 207 | 8 | f777aa1674e898e2594b2b7c029d3d05dda04df9 | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.82e-07 | 158 | 207 | 8 | 30cceb73cf5e24b692da84d33342fd3b1ad5efe5 | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-Neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.82e-07 | 158 | 207 | 8 | 47793463640f98ee5f680a1ee5786b453355fd57 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial-Hepatocyte_(Pericentral)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.60e-07 | 160 | 207 | 8 | c42bcc6c7d113f0db43febb088b75ca4ac7cb7a3 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L5-6_THEMIS_TMEM233|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.00e-06 | 179 | 207 | 8 | 747a32460b257fffca30527b56a74720eb9c12e4 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.00e-06 | 179 | 207 | 8 | 7954c0026754ab869b88ab7feb13c2f27d6e272d | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_vein-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.08e-06 | 180 | 207 | 8 | 27e8bbee388e64dd79d70b160b76d45b1f398006 | |
| ToppCell | COVID-19-kidney-tDL|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.08e-06 | 180 | 207 | 8 | 864c895b5eaedefae86f5829fa344f7b686fb59f | |
| ToppCell | COVID-19-kidney-Stressed_PCT|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.17e-06 | 181 | 207 | 8 | 6980ea624151da32b7f537f263e40fcb87a02e81 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.35e-06 | 183 | 207 | 8 | 31ab55d5f3639f5964541d5eae23044dbda3356e | |
| ToppCell | Control-Endothelial_cells-Pulmonary_venous_endothelial_cells|Control / group, cell type (main and fine annotations) | 2.35e-06 | 183 | 207 | 8 | 46be9f96755c7b65aeac061d95d15abeb6466034 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.55e-06 | 185 | 207 | 8 | 898a093757f86be3e18d2ef1f16a71f50ef81dc3 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_vein|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.76e-06 | 187 | 207 | 8 | e35716f8b482be3bf5ab79f087a9caf67a9d197a | |
| ToppCell | COVID-19-Endothelial_cells-Pulmonary_venous_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 2.76e-06 | 187 | 207 | 8 | 2d20193a6cacdfa4877457c97b0077408942186c | |
| ToppCell | COVID-19-kidney-Stressed_PCT|kidney / Disease (COVID-19 only), tissue and cell type | 2.76e-06 | 187 | 207 | 8 | acd305475f3609800af0d7bc68d83ef41228080b | |
| ToppCell | COVID-19-lung-Artery_EC|lung / Disease (COVID-19 only), tissue and cell type | 2.87e-06 | 188 | 207 | 8 | eecd7482b3c97d7f49993cb17edfab30c61232fc | |
| ToppCell | Endothelial-endothelial_cell_of_lymph_vessel|World / Lineage, Cell type, age group and donor | 2.87e-06 | 188 | 207 | 8 | 80910dcbb51990f2baed240f319456c0d3fa2065 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.0.4|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.99e-06 | 189 | 207 | 8 | 6cdd743bc46e34dc48288dda343309131b6c2d5f | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.99e-06 | 189 | 207 | 8 | 55420853f730b433ef58ac9337ac84ac78a247a0 | |
| ToppCell | IPF-Epithelial-Club|Epithelial / Disease state, Lineage and Cell class | 3.36e-06 | 192 | 207 | 8 | 356e7a820b744a0ac87352a8d0e6e8d9fa9ed7d2 | |
| ToppCell | IPF-Endothelial-VE_Venous|IPF / Disease state, Lineage and Cell class | 3.49e-06 | 193 | 207 | 8 | 29a655fa80feaabe846c90a28363b037e22d24ae | |
| ToppCell | COVID-19_Mild-Classical_Monocyte-cMono_3|Classical_Monocyte / Disease condition and Cell class | 3.91e-06 | 196 | 207 | 8 | 15397ec27167bb2fb6fec120b68bf38fc71b2670 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_neuro-secretory-Neuroendocrine|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.91e-06 | 196 | 207 | 8 | 95544097577f20ed7f4144bd940471cde0617554 | |
| ToppCell | COVID-19_Mild-Classical_Monocyte-cMono_3|COVID-19_Mild / Disease condition and Cell class | 3.91e-06 | 196 | 207 | 8 | f245e929a286cb097130572e1027b4f01be8b04d | |
| ToppCell | Bronchial-NucSeq-Endothelial-Endothelia_lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.22e-06 | 198 | 207 | 8 | fc4b7c3ad52bc5c8b40fa04a156bfbb58afa2872 | |
| ToppCell | Bronchial-NucSeq-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.22e-06 | 198 | 207 | 8 | b3a020522e064bb61949d38e442f24026e339364 | |
| ToppCell | Severe_COVID-19-Myeloid-MoAM3|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 4.38e-06 | 199 | 207 | 8 | 30523cf08815ca214877e33a2c52197ff8318557 | |
| ToppCell | BAL-Severe-Myeloid-MoAM-MoAM3-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.38e-06 | 199 | 207 | 8 | b2dc3d0af6ecd3ab01779aaa1f061cb0f941cae8 | |
| ToppCell | BAL-Severe-Myeloid-MoAM-MoAM3|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.38e-06 | 199 | 207 | 8 | 105709b97c55826a852aed27658e3b4af1738c8a | |
| ToppCell | BAL-Severe-Myeloid-MoAM-MoAM3|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.38e-06 | 199 | 207 | 8 | 0892957a49304ce4b6daa3657d76d8365ce0dd19 | |
| ToppCell | BAL-Severe-Myeloid-MoAM-MoAM3-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.38e-06 | 199 | 207 | 8 | 961ad44199871be8e09d31904d383edc865ba262 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_hypoxia/MES-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.54e-06 | 200 | 207 | 8 | 5f1de1f9305e1784c12d526f6c8bdd7d56229f9b | |
| ToppCell | LPS_only-Hematopoietic_Myeloid-Granulocytic_cells-Neutrophils|LPS_only / Treatment groups by lineage, cell group, cell type | 4.54e-06 | 200 | 207 | 8 | 3504aeba7b30cac9c428ba3871c072e2202752b4 | |
| ToppCell | LPS_only-Hematopoietic_Myeloid-Granulocytic_cells|LPS_only / Treatment groups by lineage, cell group, cell type | 4.54e-06 | 200 | 207 | 8 | c5afebbc16024c60e84a67be81c78b0bfb73ec68 | |
| ToppCell | Children_(3_yrs)-Epithelial-basal_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.86e-06 | 143 | 207 | 7 | 28e936c298a45f88d14f0146caf3d5a22d483cd5 | |
| ToppCell | LPS-IL1RA-Myeloid-Monocytes,_Macrophages-Erythroid|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.08e-06 | 144 | 207 | 7 | 7c471e332f87d60f4dbed01f3e66bf39995218d0 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-IPC_like|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 6.09e-06 | 148 | 207 | 7 | a261c6d3d9cf0311c053fca66c37d39e66db6ad8 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-IPC_like-IPs_and_early_cortical_neurons|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 6.09e-06 | 148 | 207 | 7 | c0237ba7d4040b6a497094b362dfb8b3a97a7d06 | |
| ToppCell | facs-Liver-Hepatocytes|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.60e-06 | 156 | 207 | 7 | e2cda3ad4e5f44a80133864c5a38b766afb952ce | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.74e-06 | 159 | 207 | 7 | 8680b054622f573a82b1625fb93c2d5db81d1034 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.01e-05 | 160 | 207 | 7 | 03b88dc7ad41c6ae443cab7e77ec666340bf432e | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-brush_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-05 | 162 | 207 | 7 | 6972d45f4bd4b6522bf93295f7e9dca7c6cba1f3 | |
| ToppCell | droplet-Liver-Hepatocytes-21m-Epithelial-Hepatocyte_(Pericentral,_Midlobular,_Periportal)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-05 | 164 | 207 | 7 | 90afae3cca108ebfb44ff2ec4adcbb8c68a0bdf2 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.19e-05 | 164 | 207 | 7 | b6df1e67a5ce5f2d86f4e1420f4ee931f760bf4d | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.24e-05 | 165 | 207 | 7 | 4e13fccd32029e2879e85f8966e582a46c09e4aa | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell_prolif|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.29e-05 | 166 | 207 | 7 | 8e2faca6a2e76a625de04d6098aa6f98911945c6 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.34e-05 | 167 | 207 | 7 | fe3338f99f94c0dac37e3d649dfdce82e4a56022 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Epcam____brush_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-05 | 168 | 207 | 7 | 35ce3b2b9c9997d4c101da5949c7271d6a6b8f12 | |
| ToppCell | Immune_cells-Neutrophils|Immune_cells / Lineage and Cell class | 1.39e-05 | 168 | 207 | 7 | 3539f802fe0143da1462df0618f78f9f15143f71 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.50e-05 | 170 | 207 | 7 | 03044e1436443b28dd39d5ef4fdb25c18e3a7546 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.50e-05 | 170 | 207 | 7 | fa753cc8fbd04e63c9a303da4dc17ee2ce907f92 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.50e-05 | 170 | 207 | 7 | 5570c0e825bca77613bf0ebde620cf744fa1cb84 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.50e-05 | 170 | 207 | 7 | 876b84740e15399bfff2b9c7f0b80fd759bbdb3f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.50e-05 | 170 | 207 | 7 | 1f8738acf439d893880db7e1fdc9b3615ca00c39 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-epithelial_cell_of_proximal_tubule|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.56e-05 | 171 | 207 | 7 | 05fcc72df50a380a913821b5781d9621df37d328 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-Epcam____proximal_tube_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.56e-05 | 171 | 207 | 7 | 48fc4eca18b102b5ec5050f758281292ee8e10c6 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell_prolif|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.62e-05 | 172 | 207 | 7 | c056d44e2e130ceccadfcdceb192a7f095d779c8 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.75e-05 | 174 | 207 | 7 | bc978a2148a0261a4f9d1ca5479b707e224566be | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.75e-05 | 174 | 207 | 7 | 321c6cae614d28feeee266eeb3499f2053ab79e0 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.81e-05 | 175 | 207 | 7 | 90e29945aa861082c94bb4f331161adc3a6ef899 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.81e-05 | 175 | 207 | 7 | 13843bfc8efe7c01f19ebb6735609c1eec09c698 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.81e-05 | 175 | 207 | 7 | 9d797888edb39fd12fd9cfc698a42b7bed19a5b5 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell_prolif|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.81e-05 | 175 | 207 | 7 | 90302e8a44858ef3b2a165b88284d4788d591a99 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D122|Adult / Lineage, Cell type, age group and donor | 1.88e-05 | 176 | 207 | 7 | 3fee8a367bb9755aca1b7fcc968b08e51b6e9436 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.88e-05 | 176 | 207 | 7 | 72a2a01618ce836bc843395d5095e9090759b4a6 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.88e-05 | 176 | 207 | 7 | e4b21fd6a5e0c5950f27c3e1868318e48330ae5e | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.95e-05 | 177 | 207 | 7 | 4c069f0d044a96118090b85ca592a21d6b5d9399 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Endothelial-lymphatic_endothelial-LEC2_(MADCAM1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.95e-05 | 177 | 207 | 7 | d6596a0b6fd146fefc27717c1a7dbaa3774cc644 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.95e-05 | 177 | 207 | 7 | f30d757ee8db7e10d547498dab6560473c6ed7c0 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.02e-05 | 178 | 207 | 7 | 431e7557b8e8764e16e9e48368ce6bfa3c61561a | |
| ToppCell | 10x5'v1-week_17-19-Lymphocytic_NK-T_NK-ILC_precursor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.10e-05 | 179 | 207 | 7 | d18a520568cf4b031972d3dd7d4d4bd073ac1fea | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.10e-05 | 179 | 207 | 7 | 1ac79c82c52fa95bb4e170ab20fec0f648db2134 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Endothelial-lymphatic_endothelial|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.10e-05 | 179 | 207 | 7 | 1c0c0647a111f691dae55f4ed8c51006059ce020 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.10e-05 | 179 | 207 | 7 | f65889bf1e41396979cce44a5e63f49dea2bbd9b | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.10e-05 | 179 | 207 | 7 | 445eeb0356d9fd894aa33dd9f45d893b21424149 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.17e-05 | 180 | 207 | 7 | 9e09b3dfe344b5d50520711513d389865d73a861 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L6_THEMIS_LINC00343|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.25e-05 | 181 | 207 | 7 | 9de2f2cc5f02e0ca599c9e0d2cb1e1e4b5aac112 | |
| ToppCell | facs-Liver-Hepatocytes-24m-Epithelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.33e-05 | 182 | 207 | 7 | 77ab860e2add49dad0c1ffbfc64278ad499dfbd5 | |
| ToppCell | facs-Liver-Hepatocytes-24m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.33e-05 | 182 | 207 | 7 | 4921c7d5687cc79f896b39753bb621d7e3d2972f | |
| ToppCell | facs-Liver-Hepatocytes-24m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.33e-05 | 182 | 207 | 7 | 770ce9f3f4538d0181a0181543841bc964c68274 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.33e-05 | 182 | 207 | 7 | 35b2a5625323bf0917214d3b82fafc4a8f5e75ff | |
| Drug | 4-methylpyrazole | CYP2C9 CYP2E1 RPS6KA1 RPS6KB1 IREB2 ACSL6 AOX1 SLC45A2 ACSL5 | 6.43e-08 | 84 | 204 | 9 | CID000003406 |
| Drug | glutamate | HK3 ACO1 DNER OXCT2 IREB2 PGD NDUFV1 CHRNB3 ME3 ABCB1 TRPV2 NOS1 GPLD1 CACNA1B CAD GRIK5 CPS1 PKD1L3 PDHX SLC3A1 SLC6A13 AASS ASNS SLC6A5 SLC4A4 MMUT SEC14L2 | 1.52e-07 | 962 | 204 | 27 | CID000000611 |
| Drug | ammonia | DNER BCHE ITGA2 ME3 PAOX NOS1 CACNA1B CAD ASRGL1 SLC26A9 OCA2 CPS1 PKD1L3 GBA2 PDHX ASNS SLC4A4 ENO1 SEC14L2 | 1.81e-07 | 509 | 204 | 19 | CID000000222 |
| Drug | guaiazulene | 3.12e-07 | 17 | 204 | 5 | CID000003515 | |
| Drug | cobalt-60 | MAN2B1 ACO1 DNER IREB2 ITGA2 PTGR3 GPLD1 CACNA1B TNFAIP8L2 CPA5 LAMA2 GRIK5 PKD1L3 GBA2 TFR2 MMUT | 5.10e-07 | 390 | 204 | 16 | CID000061492 |
| Drug | glycolamide | 7.09e-07 | 3 | 204 | 3 | CID000069021 | |
| Drug | doxorubicinol | 1.62e-06 | 23 | 204 | 5 | CID000083970 | |
| Drug | beta-NADP | CYP2C9 HK3 CYP2E1 ACO1 IREB2 PGD FMO6P NDUFV1 PTGR3 ME3 PYGL CRYZL1 NOS1 HIBADH PDHX AASS ENO1 | 2.23e-06 | 490 | 204 | 17 | CID000000929 |
| Drug | AC1Q68Z5 | HK3 ACO1 OXCT2 IREB2 PGD ME3 PAOX POLR1B POLR1C CPS1 PDHX SIRT2 ASNS MMUT SEC14L2 | 2.29e-06 | 386 | 204 | 15 | CID000000181 |
| Drug | glyoxylate | 4.46e-06 | 176 | 204 | 10 | CID000000760 | |
| Drug | beta-alanine | 4.47e-06 | 104 | 204 | 8 | CID000000239 | |
| Drug | racemethorphan | 5.53e-06 | 107 | 204 | 8 | CID000003008 | |
| Drug | 5,7-dimethoxyflavone | 5.84e-06 | 14 | 204 | 4 | CID000088881 | |
| Drug | p-nitroacetanilide | 7.00e-06 | 5 | 204 | 3 | CID000007691 | |
| Drug | methylmalonate semialdehyde | 9.09e-06 | 32 | 204 | 5 | CID000000296 | |
| Drug | hydroxyl radicals | CYP2C9 HK3 CYP2E1 ACO1 DNER BCHE ITGA2 FMO6P ABCB1 PAOX SYNJ2 PLCL1 DMPK NOS1 GPLD1 CAD ASRGL1 CPA5 AOX1 RBP3 SLC26A9 APLP2 CPS1 HIBADH PDHX SLC7A1 AASS ASNS ENO1 | 9.72e-06 | 1341 | 204 | 29 | CID000000961 |
| Drug | carbamyl-L-aspartate | 1.05e-05 | 16 | 204 | 4 | CID000000279 | |
| Drug | clopidogrel | 1.07e-05 | 56 | 204 | 6 | ctd:C055162 | |
| Drug | hydroxylamine | CYP2C9 ACO1 DNER OXCT2 IREB2 ITGA2 MAP3K5 NOS1 CCT7 PDHX ASNS | 1.35e-05 | 244 | 204 | 11 | CID000000787 |
| Drug | betaine | DNER OXCT2 WNK1 SLC23A2 PDHX SLC3A1 SLC6A6 SLC6A13 SLC6A5 MMUT | 1.37e-05 | 200 | 204 | 10 | CID000000247 |
| Drug | Bo 4 | 1.39e-05 | 6 | 204 | 3 | CID000177595 | |
| Drug | cubane | 1.90e-05 | 37 | 204 | 5 | CID000136090 | |
| Drug | Amiodarone | CYP2C9 MAN2B1 CYP2E1 ACO1 RPS6KB1 WNK1 PGD CHRNB3 ABCB1 TRPV2 ZNF624 PYGL GPLD1 ACSL6 FRAS1 CAD ANK1 ENC1 RBP3 LAMA2 PPARG ARHGAP35 TFR2 SLC6A6 TRNT1 ASNS SNTG2 SLC4A4 ENO1 MMUT | 2.02e-05 | 1469 | 204 | 30 | ctd:D000638 |
| Drug | allyl alcohol | 2.34e-05 | 64 | 204 | 6 | CID000007858 | |
| Drug | Ivermectin | 2.37e-05 | 95 | 204 | 7 | ctd:D007559 | |
| Drug | Rotenone | ACO1 RPS6KB1 MCM6 MAP3K5 ABCB1 S100A11 SV2B KCNJ4 BUB1B CRYZL1 IL4I1 ASRGL1 ENC1 CAMK1G PPARG NLRP3 SLC3A1 SLC6A6 SLC6A8 CD9 TLN1 ASNS EPAS1 | 2.43e-05 | 978 | 204 | 23 | ctd:D012402 |
| Drug | muramic acids | 2.71e-05 | 20 | 204 | 4 | CID000092864 | |
| Drug | carnitine | HK3 CYP2E1 OXCT2 PYGL TNFAIP8L2 PPARG CPS1 HIBADH PDHX MMUT SEC14L2 | 2.90e-05 | 265 | 204 | 11 | CID000000085 |
| Drug | Chlorine | AMACR INSRR ABCB1 SV2B KCNJ4 GNAI1 NOS1 VCP CACNA1B SLC6A15 ARHGAP35 SLC7A1 CD9 | 2.90e-05 | 367 | 204 | 13 | ctd:D002713 |
| Drug | pyruvic acid | HK3 ACO1 OXCT2 IREB2 BCHE PGD NDUFV1 ME3 PYGL CAD PDHX AASS ENO1 SLC16A8 | 3.10e-05 | 424 | 204 | 14 | CID000001060 |
| Drug | diosmin | 3.32e-05 | 21 | 204 | 4 | CID005281613 | |
| Drug | C04226 | 3.84e-05 | 8 | 204 | 3 | CID000151255 | |
| Drug | dilithium tetraborate | 3.84e-05 | 8 | 204 | 3 | CID006336545 | |
| Drug | CHEBI:38548 | 3.84e-05 | 8 | 204 | 3 | CID016126809 | |
| Drug | 3-methylitaconate | 3.84e-05 | 8 | 204 | 3 | CID006438940 | |
| Drug | 3-mercaptopropionic acid | 4.49e-05 | 44 | 204 | 5 | CID000006514 | |
| Drug | nitrosonium | 4.49e-05 | 44 | 204 | 5 | CID000084878 | |
| Drug | ABT-418 | 4.85e-05 | 23 | 204 | 4 | CID000119380 | |
| Drug | glycogen | HK3 RPS6KA1 RPS6KB1 ADGRV1 PGD ME3 KCNJ4 PYGL PPARG GBA2 PDHX SLC3A1 AASS SLC45A2 | 4.98e-05 | 443 | 204 | 14 | CID000439177 |
| Drug | decamethrin | 5.30e-05 | 146 | 204 | 8 | ctd:C017180 | |
| Drug | vinylidene chloride | CYP2E1 MYO7B AMACR ACO1 UQCR10 ME3 S100A11 SYNJ2 PYGL GNAI1 PLCL1 VASP ASRGL1 ENC1 AOX1 SLC6A15 NBEA SLC35F1 PPARG HIBADH SLC3A1 TFR2 SLC7A1 RANBP3L AASS TLN1 ASNS NINL MMUT | 5.58e-05 | 1475 | 204 | 29 | ctd:C029297 |
| Drug | NSC750266 | 5.72e-05 | 9 | 204 | 3 | CID000002819 | |
| Drug | Ferrosanol | 5.72e-05 | 9 | 204 | 3 | CID000028366 | |
| Drug | AC1L8B0O | 5.72e-05 | 9 | 204 | 3 | CID000324941 | |
| Drug | omeprazole sulfone | 5.78e-05 | 24 | 204 | 4 | CID000145900 | |
| Drug | succinate | HK3 ACO1 OXCT2 IREB2 NDUFV1 ME3 ABCB1 CAD PDHX AASS ENO1 MMUT | 5.94e-05 | 339 | 204 | 12 | CID000001110 |
| Drug | glycerol | CYP2C9 HK3 ACO1 BCHE MCM6 ADGRV1 WNK1 LSM5 ME3 PYGL GPLD1 CAD AOX1 PPARG PDHX SLC3A1 SIRT2 PARVA TNKS ENO1 | 5.99e-05 | 829 | 204 | 20 | CID000000753 |
| Drug | pyridine | 6.27e-05 | 239 | 204 | 10 | CID000001049 | |
| Drug | aspartate | ACO1 OXCT2 BCHE WNK1 ME3 CAD ASRGL1 DHX40 GRIK5 CPS1 PDHX SLC3A1 SLC6A6 ASNS CTSE | 7.20e-05 | 518 | 204 | 15 | CID000000424 |
| Drug | Fusidic acid sodium salt [751-94-0]; Up 200; 7.4uM; PC3; HT_HG-U133A | 7.20e-05 | 196 | 204 | 9 | 6754_UP | |
| Drug | guanethidine | 7.24e-05 | 113 | 204 | 7 | CID000003518 | |
| Drug | citrullin | 7.38e-05 | 153 | 204 | 8 | CID000000833 | |
| Drug | Imidurea [39236-46-9]; Up 200; 10.4uM; PC3; HT_HG-U133A | 7.78e-05 | 198 | 204 | 9 | 5062_UP | |
| Drug | NSC73306 | 7.99e-05 | 2 | 204 | 2 | ctd:C511311 | |
| Drug | Burgess reagent | 7.99e-05 | 2 | 204 | 2 | CID002724994 | |
| Drug | 1-amino-4-chloroanthraquinone | 7.99e-05 | 2 | 204 | 2 | CID000017884 | |
| Drug | tert-butylphenyl diphenyl phosphate | 7.99e-05 | 2 | 204 | 2 | ctd:C046393 | |
| Drug | 4-chloroacetophenone | 7.99e-05 | 2 | 204 | 2 | CID000007467 | |
| Drug | deoxyshikonin | 7.99e-05 | 2 | 204 | 2 | CID000098914 | |
| Drug | p-nitrophenylhydroxylamine | 7.99e-05 | 2 | 204 | 2 | CID005486551 | |
| Drug | thiobenzamide | 8.02e-05 | 26 | 204 | 4 | CID000683563 | |
| Drug | monomethyl phthalate | 8.09e-05 | 155 | 204 | 8 | CID000020392 | |
| Drug | AC1L9KLK | 8.12e-05 | 10 | 204 | 3 | CID000447216 | |
| Drug | tissue factor pathway inhibitor (TFPI | 8.12e-05 | 10 | 204 | 3 | CID000038003 | |
| Drug | 2,4-dimethylphenol | 8.12e-05 | 10 | 204 | 3 | CID000007771 | |
| Drug | Acetylcysteine | CYP2E1 AMACR RPS6KB1 IREB2 BCHE ITGA2 PGD MOAP1 MAP3K5 ABCB1 S100A11 PYGL GP2 PPARG NLRP3 MSGN1 SLC6A6 ASNS EPAS1 | 8.12e-05 | 780 | 204 | 19 | ctd:D000111 |
| Drug | hippuric acid | 8.39e-05 | 50 | 204 | 5 | CID000000464 | |
| Drug | Myosmine [532-12-7]; Up 200; 27.4uM; MCF7; HT_HG-U133A | 8.41e-05 | 200 | 204 | 9 | 4759_UP | |
| Drug | valdecoxib; Up 200; 10uM; MCF7; HT_HG-U133A | 8.41e-05 | 200 | 204 | 9 | 6403_UP | |
| Drug | phenylacetic acid | 8.55e-05 | 116 | 204 | 7 | CID000000999 | |
| Drug | oxalate | 9.25e-05 | 158 | 204 | 8 | CID000000971 | |
| Drug | nifedipine | CYP2C9 CYP2E1 ACO1 IREB2 ABCB1 DMPK CACNA1B GRIK5 PKD1L3 NLRP3 TFR2 ZNF335 SLC45A2 | 1.01e-04 | 415 | 204 | 13 | CID000004485 |
| Drug | alpha-ketoglutarate | 1.04e-04 | 254 | 204 | 10 | CID000000051 | |
| Drug | 4-nitrobiphenyl | 1.08e-04 | 28 | 204 | 4 | CID000007114 | |
| Drug | desethylamodiaquine | 1.11e-04 | 11 | 204 | 3 | CID000122068 | |
| Drug | 1,4-dinitrobenzene | 1.11e-04 | 11 | 204 | 3 | CID000007492 | |
| Drug | acetoacetate | 1.17e-04 | 122 | 204 | 7 | CID000000096 | |
| Drug | sodium | DNER BCHE WNK1 NDUFV1 ANTXR2 KCNJ4 SLC9B2 DMPK SLC23A2 ASRGL1 SLC26A9 SLC6A15 GRIK5 HUWE1 PDXK SLC3A1 SLC6A6 SLC6A13 SLC7A1 SLC6A5 SLC4A4 | 1.22e-04 | 944 | 204 | 21 | CID000000923 |
| Drug | probenecid | 1.24e-04 | 123 | 204 | 7 | CID000004911 | |
| Drug | arabinopyranose | 1.30e-04 | 261 | 204 | 10 | CID000000229 | |
| Drug | ammonium sulfate | 1.44e-04 | 126 | 204 | 7 | CID000024538 | |
| Drug | magnesium | HK3 MAN2B1 OXCT2 BCHE ITGA2 ADGRV1 ITGA9 WNK1 ABCB1 ANTXR2 KCNJ4 POLR1B DNAH5 NOS1 GPLD1 CAD LAMA2 CCT7 GRIK5 CPS1 ARHGAP35 GBA2 PDHX PDXK TRNT1 ENO1 | 1.44e-04 | 1325 | 204 | 26 | CID000000888 |
| Drug | Quinidine | 1.45e-04 | 56 | 204 | 5 | ctd:D011802 | |
| Drug | Phosphoryl | 1.46e-04 | 215 | 204 | 9 | CID006857426 | |
| Drug | j1-2 | 1.47e-04 | 12 | 204 | 3 | CID005288652 | |
| Drug | 5'-deoxypyridoxal | 1.47e-04 | 12 | 204 | 3 | CID000164889 | |
| Drug | 4-hydroxytoremifene | 1.47e-04 | 12 | 204 | 3 | CID003035198 | |
| Drug | Ccris 3504 | 1.47e-04 | 12 | 204 | 3 | CID000107874 | |
| Drug | gabapentin | 1.47e-04 | 169 | 204 | 8 | CID000003446 | |
| Drug | CO(2 | DNER PGD ME3 KCNJ4 NOS1 ANK1 OCA2 CPS1 HIBADH PDHX SLC4A4 ENO1 | 1.66e-04 | 378 | 204 | 12 | CID000000280 |
| Drug | malate | 1.67e-04 | 219 | 204 | 9 | CID000000525 | |
| Drug | Ibuprofen | CYP2C9 AMACR ABCB1 PYGL NOS1 ACSL6 PPARG PKHD1L1 SLC6A8 SLC7A1 ASNS ENO1 EPAS1 | 1.69e-04 | 437 | 204 | 13 | ctd:D007052 |
| Drug | AC1NE3MZ | 1.70e-04 | 91 | 204 | 6 | CID004636047 | |
| Drug | Gsts | 1.73e-04 | 173 | 204 | 8 | CID000128079 | |
| Drug | oxygen | CYP2C9 CYP2E1 ACO1 DNER IREB2 ADGRV1 FMO6P PAOX NOS1 EVC2 AOX1 PDXK TFR2 EPAS1 | 1.74e-04 | 499 | 204 | 14 | CID000000977 |
| Drug | Omeprazole | CYP2C9 MAN2B1 CYP2E1 ACO1 ABCB1 PYGL GPLD1 ENC1 SLC6A6 CTSE ENO1 MMUT | 1.87e-04 | 383 | 204 | 12 | ctd:D009853 |
| Drug | pyrazinoic acid | 1.90e-04 | 13 | 204 | 3 | CID000001047 | |
| Drug | AC1L18GM | 1.90e-04 | 13 | 204 | 3 | CID000000092 | |
| Drug | 5-hydroxyvalerate | 1.90e-04 | 13 | 204 | 3 | CID000025945 | |
| Drug | 2-cresol | 1.90e-04 | 13 | 204 | 3 | ctd:C034047 | |
| Disease | response to docetaxel trihydrate | 4.39e-05 | 2 | 196 | 2 | GO_1902519 | |
| Disease | carbamoyl phosphate synthetase I deficiency disease (implicated_via_orthology) | 4.39e-05 | 2 | 196 | 2 | DOID:9280 (implicated_via_orthology) | |
| Disease | Drug-Induced Liver Disease | CYP2C9 CYP2E1 MAP3K5 ABCB1 S100A11 PYGL CPS1 AASS PUM1 CTSE ENO1 | 8.92e-05 | 404 | 196 | 11 | C0860207 |
| Disease | Chemical and Drug Induced Liver Injury | CYP2C9 CYP2E1 MAP3K5 ABCB1 S100A11 PYGL CPS1 AASS PUM1 CTSE ENO1 | 8.92e-05 | 404 | 196 | 11 | C4277682 |
| Disease | Drug-Induced Acute Liver Injury | CYP2C9 CYP2E1 MAP3K5 ABCB1 S100A11 PYGL CPS1 AASS PUM1 CTSE ENO1 | 8.92e-05 | 404 | 196 | 11 | C3658290 |
| Disease | Hepatitis, Toxic | CYP2C9 CYP2E1 MAP3K5 ABCB1 S100A11 PYGL CPS1 AASS PUM1 CTSE ENO1 | 8.92e-05 | 404 | 196 | 11 | C0019193 |
| Disease | Chemically-Induced Liver Toxicity | CYP2C9 CYP2E1 MAP3K5 ABCB1 S100A11 PYGL CPS1 AASS PUM1 CTSE ENO1 | 8.92e-05 | 404 | 196 | 11 | C4279912 |
| Disease | Hepatitis, Drug-Induced | CYP2C9 CYP2E1 MAP3K5 ABCB1 S100A11 PYGL CPS1 AASS PUM1 CTSE ENO1 | 8.92e-05 | 404 | 196 | 11 | C1262760 |
| Disease | RS-10-hydroxywarfarin to RS-warfarin ratio measurement | 9.61e-05 | 110 | 196 | 6 | EFO_0803335 | |
| Disease | sleep apnea measurement | 1.29e-04 | 116 | 196 | 6 | EFO_0007817 | |
| Disease | X-25420 measurement | 1.31e-04 | 3 | 196 | 2 | EFO_0800926 | |
| Disease | Apnea | 1.31e-04 | 3 | 196 | 2 | C0003578 | |
| Disease | amino acid measurement | ADAMTS19 CNTNAP3 ITGA2 GNAI1 MGAM2 GRIK5 CPS1 HIBADH SLC6A13 SLIT1 SLIT3 PARVA SLC6A5 EPAS1 | 1.90e-04 | 678 | 196 | 14 | EFO_0005134 |
| Disease | fibrinogen measurement, plasminogen activator inhibitor 1 measurement | 2.27e-04 | 45 | 196 | 4 | EFO_0004623, EFO_0004792 | |
| Disease | Nerve Degeneration | 2.34e-04 | 83 | 196 | 5 | C0027746 | |
| Disease | Alzheimer's disease (is_implicated_in) | 2.60e-04 | 132 | 196 | 6 | DOID:10652 (is_implicated_in) | |
| Disease | suntan, skin pigmentation | 2.61e-04 | 4 | 196 | 2 | EFO_0003784, EFO_0004279 | |
| Disease | Treacher Collins syndrome | 2.61e-04 | 4 | 196 | 2 | cv:C0242387 | |
| Disease | alcoholic cardiomyopathy (biomarker_via_orthology) | 2.61e-04 | 4 | 196 | 2 | DOID:12935 (biomarker_via_orthology) | |
| Disease | Parkinson Disease | 2.62e-04 | 85 | 196 | 5 | C0030567 | |
| Disease | Colorectal Carcinoma | ABCA3 HK3 AMACR RPS6KB1 WNK1 ABCB1 BUB1B ZNF624 EVC2 CAD RBP3 PPARG CD9 ACSL5 | 2.71e-04 | 702 | 196 | 14 | C0009402 |
| Disease | Unipolar Depression | 3.58e-04 | 259 | 196 | 8 | C0041696 | |
| Disease | nervous system disorder | 4.29e-04 | 53 | 196 | 4 | C0027765 | |
| Disease | Partial Fetal Alcohol Syndrome | 4.33e-04 | 5 | 196 | 2 | C3661483 | |
| Disease | oculocutaneous albinism (implicated_via_orthology) | 4.33e-04 | 5 | 196 | 2 | DOID:0050632 (implicated_via_orthology) | |
| Disease | porphyria (implicated_via_orthology) | 4.33e-04 | 5 | 196 | 2 | DOID:13268 (implicated_via_orthology) | |
| Disease | arecaidine measurement | 4.33e-04 | 5 | 196 | 2 | EFO_0801112 | |
| Disease | Mandibulofacial dysostosis | 4.33e-04 | 5 | 196 | 2 | cv:CN004722 | |
| Disease | Alcohol Related Neurodevelopmental Disorder | 4.33e-04 | 5 | 196 | 2 | C0814154 | |
| Disease | Adenocarcinoma of lung (disorder) | 4.75e-04 | 206 | 196 | 7 | C0152013 | |
| Disease | tobacco smoke exposure measurement | 5.27e-04 | 24 | 196 | 3 | EFO_0009115 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 5.53e-04 | 152 | 196 | 6 | DOID:0060041 (implicated_via_orthology) | |
| Disease | complement component 1 q subcomponent-binding protein, mitochondrial measurement | 6.47e-04 | 6 | 196 | 2 | EFO_0020280 | |
| Disease | Treacher Collins syndrome (implicated_via_orthology) | 6.47e-04 | 6 | 196 | 2 | DOID:2908 (implicated_via_orthology) | |
| Disease | Alcohol Related Birth Defect | 6.47e-04 | 6 | 196 | 2 | C3146244 | |
| Disease | Hallux valgus | 6.88e-04 | 60 | 196 | 4 | HP_0001822 | |
| Disease | retinal vasculature measurement | DNER MCM6 EBF2 PLCL1 DNAH5 LAMA2 OCA2 CPS1 TGFBR3 SNTG2 SLC45A2 | 7.26e-04 | 517 | 196 | 11 | EFO_0010554 |
| Disease | serum IgG glycosylation measurement | ACO1 DNER IREB2 PTGR3 SBF1 ARHGAP29 TRAM1L1 RANBP3L SLIT1 SLIT3 EPAS1 | 7.98e-04 | 523 | 196 | 11 | EFO_0005193 |
| Disease | glucose metabolism disease (implicated_via_orthology) | 8.37e-04 | 28 | 196 | 3 | DOID:4194 (implicated_via_orthology) | |
| Disease | hypertension (biomarker_via_orthology) | 8.43e-04 | 227 | 196 | 7 | DOID:10763 (biomarker_via_orthology) | |
| Disease | Intellectual Disability | SCN8A ASCC3 CACNA1B SLC31A1 NBEA PDHX SLC6A8 AASS ZNF335 PUM1 | 8.64e-04 | 447 | 196 | 10 | C3714756 |
| Disease | Malignant neoplasm of breast | ADAMTS19 ABCA3 HK3 BCHE ITGA9 WNK1 ABCB1 ARID1B SYNJ2 ARHGAP29 ANK1 TCP1 LAMA2 OCA2 ITSN2 SLC6A5 ENO1 | 8.71e-04 | 1074 | 196 | 17 | C0006142 |
| Disease | level of oxylipin in blood plasma | 9.02e-04 | 7 | 196 | 2 | OBA_2050338 | |
| Disease | Albinism, Oculocutaneous | 9.02e-04 | 7 | 196 | 2 | C0078918 | |
| Disease | Oculocutaneous albinism | 9.02e-04 | 7 | 196 | 2 | cv:C0078918 | |
| Disease | histone-lysine n-methyltransferase EHMT2 measurement | 9.02e-04 | 7 | 196 | 2 | EFO_0020455 | |
| Disease | lipoprotein A measurement | 9.28e-04 | 112 | 196 | 5 | EFO_0006925 | |
| Disease | hair morphology | 9.29e-04 | 29 | 196 | 3 | EFO_0005038 | |
| Disease | polychlorinated biphenyls measurement | 9.31e-04 | 65 | 196 | 4 | EFO_0007042 | |
| Disease | temporal lobe epilepsy (biomarker_via_orthology) | 1.13e-03 | 31 | 196 | 3 | DOID:3328 (biomarker_via_orthology) | |
| Disease | Muscular Dystrophy | 1.20e-03 | 8 | 196 | 2 | C0026850 | |
| Disease | metastatic colorectal cancer, survival time | 1.20e-03 | 8 | 196 | 2 | EFO_0000714, EFO_1001480 | |
| Disease | bipolar II disorder | 1.20e-03 | 8 | 196 | 2 | EFO_0009964 | |
| Disease | total cholesterol measurement, response to escitalopram, response to citalopram | 1.20e-03 | 8 | 196 | 2 | EFO_0004574, EFO_0006329, EFO_0007871 | |
| Disease | free cholesterol change measurement, high density lipoprotein cholesterol measurement | 1.20e-03 | 8 | 196 | 2 | EFO_0004612, EFO_0020905 | |
| Disease | Hereditary spherocytosis | 1.20e-03 | 8 | 196 | 2 | C0037889 | |
| Disease | autosomal recessive intellectual developmental disorder (implicated_via_orthology) | 1.20e-03 | 8 | 196 | 2 | DOID:0060308 (implicated_via_orthology) | |
| Disease | diastolic blood pressure, self reported educational attainment | 1.20e-03 | 8 | 196 | 2 | EFO_0004784, EFO_0006336 | |
| Disease | Major Depressive Disorder | 1.25e-03 | 243 | 196 | 7 | C1269683 | |
| Disease | urinary metabolite measurement | 1.31e-03 | 245 | 196 | 7 | EFO_0005116 | |
| Disease | fatty liver disease (biomarker_via_orthology) | 1.36e-03 | 33 | 196 | 3 | DOID:9452 (biomarker_via_orthology) | |
| Disease | cognitive function measurement | IREB2 KLHL32 ME3 ARID1B LRFN2 KCNJ4 PLCL1 MYO18B DNAH5 PPFIA2 ZNF322 NBEA PPARG PKD1L3 ZNF335 ITSN2 OR2Y1 TNKS ACSL5 CPNE7 | 1.46e-03 | 1434 | 196 | 20 | EFO_0008354 |
| Disease | Neoplasm Invasiveness | 1.49e-03 | 184 | 196 | 6 | C0027626 | |
| Disease | 1-ribosyl-imidazoleacetate measurement | 1.53e-03 | 9 | 196 | 2 | EFO_0800034 | |
| Disease | epilepsy (is_implicated_in) | 1.53e-03 | 9 | 196 | 2 | DOID:1826 (is_implicated_in) | |
| Disease | alcohol dependence (implicated_via_orthology) | 1.53e-03 | 9 | 196 | 2 | DOID:0050741 (implicated_via_orthology) | |
| Disease | obsolete_red blood cell distribution width | MCM6 WNK1 CHRNB3 ME3 ABCB1 COG5 SLC23A2 SEC23B CUL4A CPSF4L CARMIL2 ANK1 ENC1 PPARG CPS1 GBA2 NLRP3 TFR2 SLC15A5 | 1.68e-03 | 1347 | 196 | 19 | EFO_0005192 |
| Disease | non-alcoholic fatty liver disease (implicated_via_orthology) | 1.75e-03 | 36 | 196 | 3 | DOID:0080208 (implicated_via_orthology) | |
| Disease | sleep latency | 1.90e-03 | 37 | 196 | 3 | EFO_0005280 | |
| Disease | 1,7-dimethylurate measurement | 1.91e-03 | 10 | 196 | 2 | EFO_0021512 | |
| Disease | leptin measurement, sex interaction measurement | 1.91e-03 | 10 | 196 | 2 | EFO_0005000, EFO_0008343 | |
| Disease | level of phosphatidylcholine | 1.91e-03 | 10 | 196 | 2 | OBA_2040179 | |
| Disease | hair colour measurement, eye colour measurement, skin pigmentation measurement | 1.91e-03 | 10 | 196 | 2 | EFO_0007009, EFO_0007822, EFO_0009764 | |
| Disease | Liver Cirrhosis, Experimental | DRAM1 AMACR ABCB1 S100A11 TMEM65 VASP ENC1 NBEA CPS1 SLC7A1 ASNS SLC4A4 CTSE | 2.11e-03 | 774 | 196 | 13 | C0023893 |
| Disease | cocaine use | 2.32e-03 | 11 | 196 | 2 | C3496069 | |
| Disease | sleep disorder (implicated_via_orthology) | 2.32e-03 | 11 | 196 | 2 | DOID:535 (implicated_via_orthology) | |
| Disease | pigmentation disease (is_implicated_in) | 2.32e-03 | 11 | 196 | 2 | DOID:10123 (is_implicated_in) | |
| Disease | guanosine diphosphate measurement | 2.32e-03 | 11 | 196 | 2 | EFO_0010494 | |
| Disease | Adverse reaction to drug | 2.41e-03 | 84 | 196 | 4 | C0041755 | |
| Disease | Drug toxicity | 2.41e-03 | 84 | 196 | 4 | C0013221 | |
| Disease | asparagine measurement | 2.56e-03 | 41 | 196 | 3 | EFO_0009766 | |
| Disease | renal cell carcinoma | 2.74e-03 | 42 | 196 | 3 | EFO_0000681 | |
| Disease | oral microbiome measurement | 2.74e-03 | 42 | 196 | 3 | EFO_0801229 | |
| Disease | Cooley's anemia | 2.77e-03 | 12 | 196 | 2 | C0002875 | |
| Disease | Thalassemia Minor | 2.77e-03 | 12 | 196 | 2 | C0085578 | |
| Disease | integral membrane protein 2B measurement | 2.77e-03 | 12 | 196 | 2 | EFO_0802634 | |
| Disease | Mental Disorders, Severe | 2.77e-03 | 12 | 196 | 2 | C4046029 | |
| Disease | beta Thalassemia | 2.77e-03 | 12 | 196 | 2 | C0005283 | |
| Disease | Diagnosis, Psychiatric | 2.77e-03 | 12 | 196 | 2 | C0376338 | |
| Disease | Parkinson Disease, Secondary Vascular | 2.77e-03 | 12 | 196 | 2 | C0751414 | |
| Disease | Atherosclerotic Parkinsonism | 2.77e-03 | 12 | 196 | 2 | C0751415 | |
| Disease | Thalassemia Intermedia | 2.77e-03 | 12 | 196 | 2 | C0271979 | |
| Disease | Secondary Parkinson Disease | 2.77e-03 | 12 | 196 | 2 | C0030569 | |
| Disease | Behavior Disorders | 2.77e-03 | 12 | 196 | 2 | C0004930 | |
| Disease | Mental disorders | 2.77e-03 | 12 | 196 | 2 | C0004936 | |
| Disease | obesity (biomarker_via_orthology) | 3.07e-03 | 147 | 196 | 5 | DOID:9970 (biomarker_via_orthology) | |
| Disease | high grade glioma (implicated_via_orthology) | 3.13e-03 | 44 | 196 | 3 | DOID:3070 (implicated_via_orthology) | |
| Disease | nevus count, cutaneous melanoma | 3.22e-03 | 91 | 196 | 4 | EFO_0000389, EFO_0004632 | |
| Disease | RAC-beta serine/threonine-protein kinase measurement | 3.26e-03 | 13 | 196 | 2 | EFO_0021989 | |
| Disease | Fetal Alcohol Spectrum Disorders | 3.26e-03 | 13 | 196 | 2 | C2985290 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VLLDAGFAVGEQSMV | 666 | Q9BXT4 | |
| VNSMDLGEFVDVFGN | 6 | A6NGE7 | |
| VLGELAAEMNGVFDT | 1011 | O60566 | |
| QDFTGVPAVVDFAAM | 86 | P21399 | |
| MLDGVFAFVLLDTAN | 116 | P08243 | |
| EGFIAVVTQDGDMIF | 96 | Q99814 | |
| VLFENADGRFEGSLM | 116 | Q05901 | |
| VNFGPTVDGDFLTDM | 316 | P06276 | |
| ITRDGFLLLQMDFGF | 466 | P11597 | |
| SSGVFMENLGITDFI | 826 | Q9BZ76 | |
| SIIIVGVGNADFAAM | 466 | Q96FN4 | |
| MQEVIAGLERFTFAF | 1 | A6NMK7 | |
| FLTDQGAAQFAAAMG | 116 | Q7L266 | |
| ADGEFMAVGAIEPQF | 226 | Q9UHK6 | |
| DLADNGFGSDMVTLV | 526 | Q6F5E8 | |
| EVLEGMSLFAELSGN | 1286 | P16157 | |
| DLFVMGGALVLESAA | 166 | Q0P651 | |
| IDLVAYGDINGFSAM | 856 | Q9UDR5 | |
| DDTGFAAFAMVIITG | 5346 | Q8WXG9 | |
| VGEEFQIVLSGRGFM | 231 | P58335 | |
| MADFGISAGQFVAVV | 1 | Q6FI81 | |
| TGGAMVIIIGDNFFD | 266 | Q9HAK2 | |
| DNFFDGLQVVFGTML | 276 | Q9HAK2 | |
| VNVDDDFCFGQVLGM | 441 | Q99758 | |
| AQGFMLLRQAATEFG | 336 | P52209 | |
| IGNLISFLEDGVTMA | 2226 | Q8NFD5 | |
| LFDNDGTVVFAIFMA | 261 | A1A5B4 | |
| IGMQVFGNIALDDDT | 1616 | Q00975 | |
| GDALMVLEFLNAFGE | 426 | Q9NRL2 | |
| AGASLDESLFVIEMG | 876 | Q06278 | |
| QELRKMGLDFAGFTA | 496 | Q04671 | |
| IVGVMFFERAFDQGA | 26 | Q9UDW1 | |
| MDGASAFGTIAIQLA | 151 | O95825 | |
| MDGITVTVADLFFAG | 286 | P05181 | |
| GGLMGFIQLNEDFIF | 241 | Q8TE59 | |
| QLFVLAGAAEEGFMT | 106 | P63096 | |
| ESGFLTEGEMALIFV | 1241 | Q9NZM3 | |
| LLQDFTGIPAMVDFA | 86 | P48200 | |
| AGSEVALAGVFMAVA | 416 | O95907 | |
| MHVNGFLGAFLFSVE | 116 | P48050 | |
| VFGEMTDIFANAGNL | 71 | P08183 | |
| GASGLVEVDYNMLAF | 86 | A6NI15 | |
| AGTGFAVAEPQIAMF | 41 | Q06481 | |
| LVGCFGMGIVANFQE | 101 | Q8N682 | |
| LLGGADIFSLSVMAF | 106 | Q8NGI4 | |
| EFVIEAGALMLADNG | 441 | Q14566 | |
| NELAIFFEGGFLMLG | 201 | Q8NGR6 | |
| QMFVALGGAECFLLA | 106 | Q8NH08 | |
| GMVVDEFQFSLTDGL | 2046 | Q86XX4 | |
| NFMGLIVALDDNGTA | 1686 | Q2M2H8 | |
| LLDFVDGMQFCSSGF | 341 | P14091 | |
| FILAAALGQMNFTGD | 26 | Q8WXQ8 | |
| TFLSRLNEFLAGEGM | 101 | Q96BY2 | |
| EQIDMLFFGGSAVSG | 981 | A6NKB5 | |
| IFITVGEDEFQGGMV | 3536 | Q9NYQ8 | |
| MGSFNTSFEDGFILV | 1 | Q8NGV0 | |
| FQGIESGVLLAMALD | 111 | A6NMU1 | |
| SISNLGMFGIDEFTA | 416 | O00330 | |
| FADMQGFTFKGVEIL | 3061 | Q02505 | |
| MISELDFQDSVFVLG | 76 | Q86X83 | |
| DGNGEFIVRMALFQD | 346 | P55259 | |
| MEAQEGGFAQSLVAL | 956 | Q86UK5 | |
| SGGELFMQLEREGIF | 176 | P23443 | |
| LDVDANAMLFVGGLT | 2271 | P24043 | |
| GTMFEAIDSVIFATG | 316 | O60774 | |
| MVTEFIFLGLSDSQG | 1 | Q8NGA8 | |
| GDVVTIGGFTFVMND | 351 | Q9HC73 | |
| NEASGLYQMFGVLAD | 441 | Q8IWF2 | |
| VMLGAGQQLFDFAAH | 131 | P52790 | |
| FDGILADAGQTVENM | 61 | Q7Z6Z7 | |
| LSDINMDGFNDVIVG | 561 | P17301 | |
| NFDLVEDGLTAMVSG | 366 | Q09013 | |
| IVGTLLGFDDFVNMV | 36 | Q9Y4Y9 | |
| GNFLVMEELQSGSFV | 31 | Q9Y5F1 | |
| MEVLGSGAFSEVFLV | 26 | Q96NX5 | |
| LEGMAFAGFVSERGV | 421 | O95248 | |
| AVSNMLLEIGGLEFS | 571 | P29475 | |
| DFQALALEGRAMGEQ | 131 | Q14671 | |
| NGLFVAFSVAGFDMI | 201 | Q8NGF1 | |
| LLGGADVFSLSVMAF | 106 | Q8NGE8 | |
| AGIAGFFTEELVVMG | 196 | Q13797 | |
| FTFGNILTNFLMGDV | 141 | Q52LW3 | |
| LAADFAQMELAVGPF | 701 | Q9UP83 | |
| VIGMDVAASEFFRSG | 241 | P06733 | |
| GEVMAIGRTFEESFQ | 796 | P31327 | |
| AVQESQCMLGLFFGF | 81 | P21926 | |
| FELNVQAFAGGAMGA | 786 | Q9HCG7 | |
| VLAAGSAVFDAMFNG | 96 | Q9H0C5 | |
| TLVLLMFNEGDGFSF | 596 | Q13619 | |
| GVGNADFTDMQVLDG | 546 | Q9UBL6 | |
| VGFFQGDIRLLADDM | 326 | Q9ULC5 | |
| SAPAFIMAGEQVFQD | 276 | Q9Y264 | |
| GDGLNAIVVFAVCFM | 161 | Q12982 | |
| FAGTAILLMDFGVTN | 151 | Q8N5U1 | |
| QMTLGLRFLEDTFGN | 171 | O00754 | |
| VFVFQGAGEAAMGIA | 331 | Q16798 | |
| GAFQQFRMEGVSEDL | 61 | Q8NHY5 | |
| QILLMFTATGEDFRG | 56 | P14616 | |
| GQTLIRMDFFFTEGA | 136 | Q96LR7 | |
| GNQIFIMGGDTEFSA | 491 | O14682 | |
| VGEALAGMELFLFLT | 436 | P11712 | |
| DNFFDGLQVVFGTML | 286 | Q9H4W6 | |
| GIVEDSSNILGFSMF | 256 | Q16478 | |
| LVINTAGEMAGAFVA | 61 | O15431 | |
| AGEMAGAFVAVFLLA | 66 | O15431 | |
| EEMLALGNNHFIGFV | 271 | Q8NFT8 | |
| MAGDILVFLTGQFEI | 271 | Q8IX18 | |
| MAQFVQVLAEIGDFG | 1 | Q9Y226 | |
| QFMSDGADVGFGIFL | 306 | O76054 | |
| NLFAALSVMIAGFFE | 391 | A6NIM6 | |
| MIGVVLFDFAADFID | 146 | Q9UMX9 | |
| DFMLLAVGIIAASAF | 251 | Q8N815 | |
| SSGVFMENLGITDFI | 826 | Q96NU0 | |
| QEVSFNMLDAADGGL | 146 | Q8TE73 | |
| AGIKLIFFFDGMVEQ | 81 | Q96EK7 | |
| GFMETEAAAQESLGL | 851 | O75334 | |
| FLDSRGVAMVLAVGF | 526 | Q6UY18 | |
| MFILTGFTDDFELQV | 41 | Q8NGG3 | |
| VQLLGDVMSEDGFFY | 226 | Q96RQ9 | |
| GFIAGLESEFMETLS | 381 | Q6QHF9 | |
| MAQLFIEHLFGGSEV | 96 | Q8NGN8 | |
| FMEGVIVLANSGLFS | 191 | Q8NGF8 | |
| LGSFSENGFIKIFME | 741 | Q99683 | |
| RILFLMDGFDELQGA | 296 | Q96P20 | |
| GAAFQEDDVIMLNGT | 161 | Q9BY42 | |
| VQGTGLAFIAFTEAM | 436 | Q9H2J7 | |
| RDLTINSMFLGFDGT | 151 | Q96Q11 | |
| GFAIFSILGFMAQEQ | 341 | P31641 | |
| SILGFMAQEQGVDIA | 346 | P31641 | |
| LFFVLGLALMADGVE | 111 | Q7L1I2 | |
| GLALMADGVEVFVVS | 116 | Q7L1I2 | |
| FAVGFEEMVELSAGN | 581 | O15056 | |
| ESFIRGFMTAAGLQI | 201 | Q7LBE3 | |
| AGFVIFSVIGFMANE | 516 | Q9Y345 | |
| GVGGQEAMLFTSEIF | 136 | Q9UGC7 | |
| LMDFDALVQAQTGLG | 336 | P49821 | |
| MLSFLAATGDDGQAV | 1116 | Q6ZNJ1 | |
| LNLLVGGEFDLEMNF | 96 | Q8NFP9 | |
| GVLISEGQGFMTREF | 366 | P37231 | |
| LVAFDGMFAQVETAF | 2961 | Q96Q15 | |
| GMFAQVETAFSLLVE | 2966 | Q96Q15 | |
| VFVMTFTLDDGTGVL | 541 | Q9NUX5 | |
| LEMSLVEFGNIGEAF | 386 | Q7Z443 | |
| LMAAGSFDDILAITG | 271 | Q86UD5 | |
| AAGGEADMDFLRNLF | 31 | Q8IXJ6 | |
| IFGTMEDFENLVAAI | 186 | Q07837 | |
| IGINGDFFANMVVDA | 161 | P17987 | |
| TFILRGGAEQFMEET | 371 | Q99832 | |
| MEAGNQTGFLEFILL | 1 | Q96RA2 | |
| DFSEFLNLIGGLAMA | 76 | P31949 | |
| GFVVFSILGFMAAEQ | 356 | P48029 | |
| DQAADQTGMLFVGDA | 106 | Q9NY99 | |
| LEFDMVGIDAAIANA | 61 | O15160 | |
| NVSFAFELMQDGGLE | 326 | Q9NVD7 | |
| DDGSGFAFPDQVLAM | 316 | Q9Y2I6 | |
| LEGNDGLSFIMSNFE | 1016 | Q9NRY4 | |
| AVGTTEFALLGAMAV | 106 | Q8NGU2 | |
| VDAVFVGTGDLFAAM | 226 | O00764 | |
| AALEFEDGMYANLGI | 306 | Q9BYC2 | |
| FNGDFRMAFGATLDV | 396 | Q15437 | |
| DAVFELISMGFNVAL | 106 | Q5VW32 | |
| LTFMVGGVEDEFAAA | 171 | P31937 | |
| VGFFQGDIRLLSDDM | 341 | Q9UKU0 | |
| GREAIESGAAFLFMT | 86 | Q8N3C0 | |
| GSFVDLGILDVMQIF | 836 | Q8N3C0 | |
| EALDGFFLAIMTDGS | 116 | O15516 | |
| FMVDFGNSEVLIVTG | 516 | Q9BXT8 | |
| AFDGAASVQELMLTG | 576 | O75094 | |
| FGAFFSGIQLAIMEH | 256 | Q5T1Q4 | |
| RGAFMQLITVAEGFS | 726 | Q8TCY9 | |
| FVAQEGGDIVTFDMC | 481 | Q8N2E2 | |
| TVFEAADVDGNGIML | 246 | Q15111 | |
| MSFFGFGQSVEVEIL | 1 | Q4G0F5 | |
| GEIMAAVFFSVGRLS | 16 | Q9P2J8 | |
| GDAGFVLVAFGSMLN | 291 | Q6NUS8 | |
| GMFFLLGLVFEGTAE | 31 | Q8N609 | |
| QGAMTALSFGEVDFT | 96 | Q6P589 | |
| RFDMFGDGELLTQVS | 1046 | P10745 | |
| TAMFVGGCVAFILDN | 556 | Q9UGH3 | |
| DLEFLAKMTNGFSGA | 671 | P55072 | |
| ASGAVAAVMAFLFDL | 391 | P30825 | |
| QDFSTFLEAGVEMAG | 1276 | Q9Y490 | |
| NFVFGENMVERVLGT | 211 | Q86VV4 | |
| AIGFGLARMENQAFD | 266 | Q15035 | |
| EGEVAGLDMNISQFL | 1021 | O95271 | |
| AIFSILGFMSQEQGV | 331 | Q9NSD5 | |
| GLEQGFLRTMGAIDF | 136 | P80108 | |
| CESGFLLGMDFVAQQ | 326 | Q6U7Q0 | |
| FKFTIGMGELAFQEQ | 601 | Q9Y5S1 | |
| MAQGLVTFADVAIDF | 1 | Q9NQX6 | |
| AVGNLVFTGIFTAEM | 786 | Q9UQD0 | |
| GSNFGFEILEISVMI | 1936 | Q86WI1 | |
| TEGLCNMGFAEAFLE | 256 | A6NIE6 | |
| MGIGRSFEEAFQKAL | 766 | P27708 | |
| MGCLVLAEVGFFSQE | 621 | O15195 | |
| EGESNFLVFSQMLAG | 751 | Q8IUG5 | |
| ESVGGAMFDLAVDAL | 246 | Q8N4Q0 | |
| IGFGFLDNAIMIVAG | 126 | Q6PI78 | |
| AEVFGEGNMFAVSPV | 256 | Q9UPU5 | |
| LGDATDNMQGVLESF | 491 | Q9Y6R1 | |
| DVMLENFALVATLGF | 41 | Q9HCX3 | |
| AVGMSNDGRFLKFDI | 211 | Q9H4A3 | |
| FMNVAIFEDEVFAGV | 641 | Q9H9Y6 | |
| LVAFDQMVNLSIDGG | 1251 | O75093 | |
| AVADAAMAQAQGLFG | 1301 | Q9H4Z2 | |
| AEEAGEENLFIFGMR | 701 | P06737 | |
| QAMFLQFLGEGRLED | 141 | Q9UP52 | |
| GLDTLTVMGIAFAAF | 781 | Q03167 | |
| QFAAGMASALEALEG | 101 | P50552 | |
| VAVMGDFLFVAGGEV | 341 | Q96NJ5 | |
| FRGFSFVATGLMEDD | 376 | Q15418 | |
| GGLLAFGMAFAVVDA | 6 | Q9ULH4 | |
| AIEAMAAVFGGTQSL | 371 | P22033 | |
| LHLGNVGFMASVFEN | 326 | Q6PIF6 |